Second Interim Report to the Public on
CERTAIN PHARMACEUTICALS AND INTERMEDIATE CHEMICALS: IDENTIFI CATION OF APPLICABLE 6-DIGIT HS SUBHEADINGS. .· FOR PRODUCTS ·coVERED BY THE PROPOSED URUGUAY ROUND PHARMACEUTICAL A,GREEMENT
Investigation No. 332-322
USITC PUBLICATION 2500 APRIL 1992
,f~· United States International Trade Commission . ·J,
Washington, DC 20436 . ·-~}~~:; . _:, -~;<$f ·!•;. UNITED STATES INTERNATIONAL TRADE COMMISSION COMMISSIONERS Don E. Newquist, Chairman Anne E. Brunsdale, Vice Chairman David B. Rohr Carol T. Crawford Janet A. Nuzum Peter S. Watson
Office of Operations Charles W. Ervin, Director
Office of Industries Rohen A. Rogowsky, Director
This report was prepared principally by Eli?.abcth R. Ncsbiu Project Leader Aimison Jonnard Edward Matusik David Michels James Raftery Office of Industries David Beck Office of Tariff Affairs and Trade Agreements With assistance from Paul Daniels James Gill Office ofInformation Resources Management Under the direction of John J. Gersic, Chief Energy & Chemicals Division and Edmund D. Cappuccilli, Chief Energy, Petroleum, Benzenoid Chemicals, and Rubber and Plastics Branch · Energy & Chemicals Division Additional assistance provided by Brenda Carroll and Keilh Hipp With special assistance from U.S. Customs Service
Address all communications to Kenneth R. Mason, Secreta·ry to the Commission United States International Trade Commission Washington, DC 20436 PREFACE
This report is the second of two interim reports to the public pertaining to Commission investigation No. 332-322, entitled Certain Pharmaceuticals and Intermediate Chemicals; Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement. The investigation was instituted following receipt of a letter from the United States Trade Representative (USTR) on January 27, 1992, requesting that the Commission conduct an investigation under section 332(g) of the Tariff Act of 1930 (see appendix A for a copy of the USTR' s request)·. The Commission was also asked to identify each instance where there is a known difference in ~inion among countries on the classification of a product. USTR has requested the Commissioner of the U.S. Customs Service (Customs) to provide Commission staff with any necessary technical assistance. The USTR asked the Commission to submit its report by June 1, 1992.
The purpose of the investigation is to provide the USTR with a rE[!port listing the 6-digit Harmonized Commodity Description and Coding System (HS) subheadings for those pharmaceuticals having an International Non-proprietary Name (INN) and certain intermediate chemical products (used primarily in the production of pharmaceuticals) to be covered under the proposed nzero-for-zeron initiative on pharmaceuticals. This initiative, currently being negotiated under the Uruguay Round market access negotiations, provides for reciprocal duty-free treatment among major trading partners for pharmaceuticals and certain intermediate chemical products. As of the date of institution of this investigation, the request from the USTR regarding this initiative covered a total of 6,085- INNs and 272 intermediate chemicals.
Inasmuch as the USTR asked that the Commission make its work available to the USTR and the public on a flow basis, the Commission plans, as indicated in the Commission's notice of institution, reproduced in appendix B of this report as published in the Federal Register, to make available two interim reports to the public. Each interim report will contain a listing of the classifications completed by that phase of the investigation. These preliminary 6-digit HS classifications were derived on the basis that the chemical names provided represented separate chemically defined compounds. No public hearing will be held in connection with this investigation. However, interested parties are requested to submit written statements to the Commission regarding any discrepancies between their current classifications for the chemicals under consideration and the classifications presented by the Commission. The deadline for submissions regarding this second interim report is close of business (5;15 pm) on May 8, 1992 (see appendix B for more information) . Proof of such classification discrepancies are requested either in the form of either official rulings by the U.S. Customs Service (Customs) or copies of prior communications with Customs on this issue. The Commission will work with Customs personnel to resolve any classification discrepancies presented by interested parties. It should be noted that the classifications presented in the Commission's report(s) are not intended to be and wil_l not be binding upon the Customs Service and should not be considered formal or informal rulings or advice.
i
CONTENTS
Preface i
Tables
1. Tariff Classifications: Phannaceuticals having an INN and their corresponding HTS subheadings 1
Appendices
A. Copy of the letter of request from the United States Trade Representative A-1
B. Copy of the Commission's notice of institution of investigation, as published in the Fesieral Register B-1
iii
Table 1 Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2924.10 ACBNBORAMIC ACID 3003.90 BUTHALITAL SODIUM * ACBTORATB 2931.60 CALCIUM SODIUM FBRRICLATB * ACISTRATB * CAMSILATB 2936.10 ACITRBTIN * CARBBSILATB 2918.21 ADAPALBNB 2931.00 CARBOPLATIN 2926.90 ALMOKALANT 2933. 71 CARMOFOR 2914. 70 AMCINAFAL 3001.20 CARPBRITIDB 2914. 70 AMCINAFIDB 2924.29 CASOKBFAMIDB ** AMINOACID 2934.10 CBFCLIDIN 2933.71 AMPHBNIDONB 2934.10 CBFDALOXIMB 2922.30 AMRUBICIN 2941.90 CBFDINIR 2933.90 AMTOLMBTIN GUACIL 2934.10 CBFBMPIDONB .... 2937.99 ANAGBSTONB 2941.90 CBFBPIMB 2933 .59 ANAGRBLIDB 2934.10 CBFBTBCOL 293'. 90 APRIKALIM 2941.90 CBFMBPIDIUM CHLORIDE 2940.00 APROSULATB SODIUM 2934.10 CBFQUINOMB 2922.49 ARAPROFBN 2934.10 CBFTBRAM * AXBTIL 2934.10 CBFUZONAM 2933.39 BARNIDIPINB 3001.90 CBLMOLBOKIN 2934.90 BBCLICONAZOLB ** CBTRORBLIX 2937.29 BBCLOMBTASONB ** CHOLINB ALFOSCBRATB 2916.31 BBMBSBTRON 2918.90 CICAPROST 2933.90 BBRTOSAMIL 2937.99 CICLBSONIDB * BBSILATB 2934.90 CICLBTANINB 2922.49 BBTAMIPRON * CICLOTATB * BBZOMIL 2931.00 CIDBFBRRON 2934.90 BIMAJCALIM 2934.90 CIFOSTODINB 2933.90 BINDARIT 2933.90 CILAZAPRILAT 2934.90 BINOSPIRONB 2933.39 CILOBRADINB 2939.90 BIORBSMBTHRIN 2933.90 CILOFUNGIN 2933 .90 BRINAZARONB 2933.29 CILUTAZOLINB 2939.90 BROVINCAMINB 2926.90 CIMATBROL 2937.21 BUDBSONIDB 2934.90 CINOXOPAZIDB * BUNAPSILATB 2914 .50 CIOTSRONBL * BUTBPRATB * CIPIONATB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq INN _subhe_adinq INN
2933.40 CIPRBFADOL 2928.00 DBFBROXAMINB 2933.40 CIPROQUINATB 3913.90 DBFIBROTIDB 2934.90 CISCONAZOLB 2934.90 DBFLAZACORT 2930.90 CISTINBXINB 2929.90 DBFOSFAMIDB 2934.90 CITATBPINB 2939.90 DBHYDROBMBTINB 2924.21 CLANFBNUR 2914 .29 DBLANTBRONB 2941.50 CLARITHROMYCIN 2922.49 DBLAPRIL 2933 .69 CLAZURIL 2939.60 DBLBRGOTRILB 2934.90 CLBNTIAZBM 2935.00 DBLFANTRINB 2933.40 CLIMIQUALINB 2933.90 DBLFAPRAZINB 2922.29 CLIROPAMINB 2937.90 DBLMADINONB 2922.50 CLOMIFBNOXIDB 2933.90 DBLMBTACIN 2934 .,90 CLOPIDOGRBL 2934.90 DBLMOPINOL "' •• CLOSILATB 2933.90 DBLORAZBPAM •• CORTICORBLIN 2917.19 DBLOXOLONB •• CRILANOMBR 2918.90 DBLPROSTBNATB •• CROBBFATB 2903.69 DBMBRBXINB •• CROMACATB 2924.29 DBMBCARIUM BROMIDB •• CROMBSILATB 2939.90 DBMBCOLCINB •• DALFOPRISTIN 2941.30 DBMBCYCLINB •• DALTBPARIN SODIUM 2914 .29 DBMBGBSTONB •• DAJNASTATIN 2921.49 DBMBLV8RINB •• DAPOXBTINB 2928.00 DBMBXIPTILINB •• DBANIL 2933.29 DBMOCONAZOLB •• DBBROPOL 2934.90 DBMOXYTOCIN •• DBCIL 2924.29 DBNATONIUM BBNZOATB 2924.29 DBCIMBMIDB 2922.50 DBNAVBRINB 2934.90 DBCITABINB 2933.90 DBNBUFYLLINB 2933.39 DBCITROPINB 2918.90 DBNIPRIDB 2933.39 DBCLBNPBRONB 2922.50 DBNOPAMINB 2933.59 DBCLOXIZINB 2933.90 DBNPIDAZONB 2922.50 DBCOMINOL 2933.29 DBNZIMOL 2933.90 DBCOQUINATB 2933.90 DBPRAMINB 2921.19 DBCTAFLUR 2937.29 DBPRODONB 2923.90 DBDITONIUM BROMIDE 2918.90 DBPRQSTIL Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadine:t .. _ _lmi___ __ subheadine:t INN
2933.39 DBPTROPINB 2933.90 DBXCLAMOL 2933.40 DBQUALINIUM CHLORIDB 2933.39 DBXBTIMIDB ** DBRAMCICLANB 2934.10 DBXBTOZOLINB 2939.90 DBRPANICATB 2921.59 DBXFBNFLURAMINB 2914 .69 DBSASPIDIN 2916.39 DBXIBUPROFBN 2933.90 DBSCICLOVIR 2933.90 DBXIMAFBN 2932.90 DBSCINOLONB 2933.79 DBXINDOPROFBN 2939.90 DBSBRPIDINB 2933.39 DBXIVACAINB 2909.19 DBSFLURANB 2933.29 DBXLOFBXIDINB 2933.90 DBSGLUGASTRIN ** DBXLOXIGLUMIDB 2933.90 DBSIPRAMINB 2933.90 DBXMBDBTOMIDINB 2938.90 DBSLANOSIDB· ** I DBXNAFBNODONB w 2937.99 DBSLORBLIN 2930.90 DBXORMAPLATIN 2924.29 DBSMBTHYLMORAMIDB 2934.90 DBXOXADROL 2934.90 DBSMOPRBSSIN 2922.50 DBXPROPRANOLOL 2939.60 DBSOCRIPTINB 2922.19 DBXPROXIBtrrBNB 2906.19 DBSOOBSTRBL 2933.90 DBXRAZOXANB 2939.10 DBSOMORPHINB. 2922.50 DBXSBCOVBRINB 2937.29 DBSONIDB 2922.49 DBXTILIDINB 2914. 70 DBSOXIMBTASONB 2909.20 DBXTRANOMBR 2937.29 DBSOXYCORTONB 2930.90 DBXTRIFBRRON 2939.90 DBT.AJMIUM BITARTRATB 2922.19 DBXTROFBMINB 2922.50 DBTANOSAL 2933.90 DBXTROMBTHORPHAN 2922.50 DBTBRBNOL 2934.90 DBXTROMORAMIDB 2933.90 DBTIRBLIX 2922.19 DBXTROPROPOXYPHBNB 2933.29 DBTOMIDINB 2933.90 DBXTRORPHAN 2932.90 DBTORUBICIN ** DBXVBRAPAMIL 2930.90 DBTRALFATB 2933.79 DBZAGUANINB 2922.50 DBTROTHYRONINB 2922.29 DBZOCINB 2926.90 DBVAPAMIL 2918.90 DIACBRBIN 2933.90 DBVAZBPIDB 2924.29 DIACBTAMATB 2937.99 DBXAMBTHASONB ACBFURATB 2924.29 DIACBTOLOL 2934.90 DBXAMISOLB 2924.29 DIAMFBNBTIDB 2933.39 DBXBROMPHBNIRAMINB 2933.39 DIAMOCAINB 2933.39 DBXCHLORPHBNIRAMINB 2924.29 DIAMPROMIDB Table.1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinci INN ______subheadinq INN
2932.29 DIARBARONB 2933.90 DIDANOSINB 2930.90 DIATHDl)SULFONB 2932.90 DIDROVALTRATB 2933.59 DIAVBRIDINB 2926.90 DIBNOGBST 2933.90 DIAZIQUONB 2934.90 DIBTHADIONB 2941.90 DIBBKACIN 2934.30 DIBTHAZINB 2921.49 DIBBMBTHINB 2933.59 DIBTHYLCARBAMAZINB 2933.90 DIBBNZBPIN 2934.90 DIBTHYLTHIAMBUTBNB 2925.20 DIBROMPROPAMIDINB 2922.50 DIBTIPBN 2924.29 DIBROMSALAN 2933.51 DIPBBARBAMATB 2933.59 DIBROSPIDIUM CHLORIDE 2922.50 DIPBMBRINB ** DIBUDINATB 2933.39 DIPBMBTORBX 2920.90 DIBUNATB 2933.19 DIPBNAMIZOLB ~ 2909.49 DIBUPROL 2934.90 DIPBNCLOXAZINB 2933 .11 DIBUPYRONB 2933.39 DIFBNIDOL 2924.29 DIBUSAOOL 2933.39 DIPBNOXIMIDB 2933.90 DICARBINB 2933.39 DIPBNOXIN 2924.29 DICARFBN 2931.00 DIPBTARSONB 2914. 70 DICHLORISONB 2922.19 DIPBTBROL 2934.90 DICHLORMBZANONB 2937.22 DIPLORASONB 2931.00 DICHLOROPHBNARSINB 2933.90 DIFLOXACIN 2906.29 DICHLOROXYLBNOL 2933.59 DIPLUANAZINB 2931.00 DICIFBRRON 2937.22 DIFLUCORTOLONB 2932.29 DICIRBNONB 2935.00 DIFLUMIDONB 2933.69 DICLAZURIL 2915.60 DIFLUPRBDNATB 2922.49 DICLOFBNAC 2933.90 DIFTALONB 2933.40 DICLOFBNSINB 2938.90 DIGITOXIN 2932.19 DICLOFURIMB 2932.29 DIGOLIL 2924.29 DICLOMBTIDB 2933.39 DIHBXYVBRINB 2933.39 DICLONIXIN 2933.90 DIHYDRALAZINB 2924.10 DICLORALURBA 2939.10 DIHYDROCODBINB 2941.10 DICLOXACILLIN 2939.60 DIHYDROBRGOTAMINB 2922.49 DICOBALT BDBTATB 2906.19 DIHYDROTACHYSTEROL 2933.39 DICOLINIUM IODIDB 2921.49 DIISOPROMINB 2908.20 DICRBSULBNB 2933.90 DILAZBP 2922.19 DICYCLOVBRINB 2924.29 DILBVALOL Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their cor~esponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World! Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq INN subheadim:1 INN
2933.39 DILMBPONB 2924.29 DIMBVAMIDB 2924.29 DILOXARIDB 2927.00 DIMINAZBNB 2934.90 DILTIAZBM 2918.90 DIMOXAPROST 2933.59 . DIMABBFYLLINB 2933.40 DIMOXYLINB 2934.20 DIMAZOLB 2924.29 DINALIN 2921.30 DIMBCAMINB 2924.29 DINAZAFONB 2933.39 DIMBCOLONIUM IODIDB 2939.50 DINIPROFYLLINB 2918.90 DIMBCROTIC ACID 2918.90 DINOPROST 2921.49 DIMBPADANB 2933.39 DIODONB 2932.90 DIMBFLINB 2922.12 DIOLAMINB 2934.90 DIMBLAZINB 2938.10 DIOSMIN 2933.90 DIMBMORFAN 2932.90 DIOXADILOL
UI 2922.SO DIMBNOXADOL 2934.90 DIOXADROL 2922.19 DIMBPHBPTANOL ... 2932.90 DIOXAMATB 2922.19 DIMBPRANOL 2934.90 DIOXAPHBTYL Btn'YRATB 2914.49 DIMBPRBGNBN 2922.50 DIOXBTHBDRINB 2932.90 DIMBPROZAN 2922.50 DIOXIFBDRINB 2930.90 DIMBRCAPROL 2933.39 DIPBRODON 2930.90 DIMBSNA 2924.29 DIPHBNAN 2914.49 DIMBSONB 2922.19 DIPHBNHYDRAMINB 2933~90 DIMBTACRINB 2933.39 DIPHBNYLPYRALINB 2921.49 DIMBTAMFBTAMINB 2928.00 DIPHOXAZIDB 2934.90 DIMBTHADIONB 2933.39 DIPIPANONB 2939.50 DIMBTHAZAN 2933.39 DIPIPROVERINB 2904.90 DIMBTHIODAL SODIUM 2922.50 DIPIVBFRINB 2937.92 DIMBTHISTBRONB 2923.90 DIPONIUM BROMIDB 2933.59 DIMBTHOLIZINB 2922.50 DIPRAFBNONB 2934.30 DIMBTHOXANATB 2939.10 DIPRBNORPHINB 2934.90 DIMBTHYLTHIAMBUTBNB 2921.19 DIPROBUTINB 2939.90 DIMBTHYLTUBOCURARINIUM CHLORIDE 2930.90 DIPROFBNB 3910.00 DIMBTICONB 2932.19 DIPROGULIC ACID 2933. 39 DIMBTINDl~NB 2941.90 DIPROLBANDOMYCIN 2933.90 DIMBTIPIRIUM BROMIDE 2939.50 DIPROPHYLLINB 2922.50 DIMBTOFRINB 2933.59 DIPROQUALONB 2935.00 DIMBTOTIAZINB 2933.90 DIPROTBVERINB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings
(One asterisk (*) denotes INN names for radicals and groups proposed by the World 1 Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS sµbheading INN subheading INN
2934.90 DIPROXADOL 2923.90 DODECLONIUM BROMIDE 2933.59 DIPYRIDA!l)LB 2924.29 DOF.AMIUM CHLORIDE 2933.39 DIPYRI'nlIONB 2934.90 DOFBTILIDE 2918. 29 DIPYROCBTYL ** DOFOSFATB 2941.90 DIRITHROMYCIN ** DOLASETRON 2922.19 DISIQOONIUM CHLORIDE 2933.79 DOLIRACBTAM 2933.39 DISOBtn'AMIDE 2933.29 DOMAZOLINB 2924.29 DISOFENIN 2932.19 DOMIODOL 2932.90 DISOGLUSIDB 2923.90 DOMIPHEN BROMIDE 2934.90 DISOXARIL 2933.90 DOMIPIZONB
2933.39 DISTIGMINB BROMIDE I 2916.20 DOMOPRBDNATE 2935.00 DISULBRGINB I 2932.90 DOMOXIN 0\ 2935.00 DISULFAMIDE 2933.39 DOMPERIDONB 2933. 90 DISUPRAZOLE 2933.90 DONBTIDINB 293' .90 DITAZOLB 2924.29 DOPAMANTINB 2933.90 DITEKIRBN 2922.29 DOPAMINE 2933.39 DITERCALINIUM CHLORIDE 2922.29 DOPBXAMINB 2907.29 DI'nlRANOL 2933.90 DOPROPIDIL 2930.90 DITIOMUSTINB 2933.59 DOQUALAST 2935.00 DITOLAMIDB 2932.90 DORAMBCTIN 2930.90 DITOPHAL 2933.39 DO RAST I NB 2922.50 DIVABtn'BROL 2932.90 DORBPTIDE 2933.90 DIVAPLON 2906.29 DORBTINBL 2930.90 DIXANTHOGEN 2933.90 DOSERGOSIDB 2933.69 DIZATRIFONB 2932.90 DOSMALFATB 2917.19 DIZOCILPINB 2934.90 DOSULBPIN 2922.49 DL-AMINOACID 2934.90 DOTARIZINB 2921.49 DOBUPRIDE 2934.90 DOTBFONIUM BROMIDE 2922.29 DOBtn'.AMINB 2933.90 DOXACURIUM CHLORIDE 2924.29 IXY'..ARPAMINB 2932.90 DOXAMINOL 2914.69 DOCBBENONB 2934.90 DOXAPRAM 2916.39' DOCETAXOL 2918.90 DOXAPROST 2934.90 DOCONAZOLE 2934.90 DOXAZOSIN 2916.39 DOCONBXBNT 2933.90 DOXBFAZEPAM ** DOCOSIL 2933.29 OOXBNITOIN• Table 1--Continued Tariff ,Classifications: . Pharmaceuticals having an INN and their cor~esponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subbeading INN sµbheadinq INN
2932.90 DOXBPIN 2924.29 DULOZAFONB 2914. 70 DOXIBBTASOL 2937.99 DUMORBLIN 2934.90 DOXIFLURIDINB 2933.90 DUOMBTACIN 2939.50 DOXOFYLLINB 2934.30 DUOPBRONB 2941.9·0 DOXORUBICIN 2933.79 DUPRACBTAM 2934.90 DOXPICOMINB 3504.00 DUTBPLASB 2933.39 DOXYLAMINB 2933.39 DYCLONINB 2933.90 DRAFLAZINB 2937.92 DYDROGBSTBRONB 2933.90 DRAMBDILOL 2933.39 BBASTINB 2933.90 DRAQUINOLOL 2933.39 BBBRCONAZOLB 2933.90 DRAZIDOX 2933.29 BBIRATIDB 2933 .9,0 DRIBBNDAZOLB 2934.10 BBROTIDINB -.I 2922.30 DRINIDBNB 2934.90 BBSBLBN 2922.19 DROBULINB 2934.90 BCABBT 2937.22 DROCINONIDB 2934.90 BCASTOLOL 2933.39 DROCLIDINIUM BROMIDE 2921.59 BCIPRAMIDIL 2922.19 DROFBNINB 2933.19 BCLANAMINB 2922.50 DROLOXIFBNB 2934.90 BCLAZOLAST 2933.90 DROMBTRIZOLB 3001.90 BCOGRAMOSTIM 2932.90 DRONABINOL 2940.00 BCOMUSTINB 2933.39 DROPBMPINB 2933.59 BDATRBXATB 2933.90 DROPBRIDOL 2923.10 BDBLFOSINB 2921.49 DROPRBNILAMINB 2937.99 BDIFOLONB 2933.59 DROPROPIZINB * BDISILATB 2932.19 DROSPIRBNONB 2934.90 BFAROXAN 2937.!J9 DROSTANOLONB 2933 .29 BFBTOZOLB 2933.40 DROTAVBRINB 2933.90 BFLUMAST 2933.39 DROTBBANOL 2922.49 i BGTAZIC ACID 2934.90 DROXACIN ** i BGUALBN 2933 .39 DROXICAINIDB 2933.59 BLBANIZINB 2934.90 DROXICAM 3505.10 BLDBXOMBR 2921.29 DROXIDOPA 2934.90 BLGODIPINB 2933.39 DROXYPROPINB 2934.90 BLNADIPINB 2941. 90 DUAZOMYCIN 2938.90 BLSAMITRUCIN .. a10 an nnT .n1:'TADll>"l'12 2914.49 ELTANOLONE Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq ______INN subheading INN
2934.90 BLTOPRAZINB ••• LANRBOTIDB 2933.59 BLZIVBRINB ** LAUR IL ** BMBONATB ** LAURILSULFATB ** BNANTATB ** LBNOGRASTIM ** BNGLITAZONB ** LBUCIGLUMBR ** BNLOPLATIN ** LBURUBICIN ** BNTACAPONB ** LBVDOBt1I'AMINB ** BPROBBMIDB ** LBVODROPROPIZINB ** BRBUMINB ** LBVOFLOXACIN ** BSILATB ** LBXITHROMYCIN ** BSPATROPATB ** LIAROZOLB ** BSTOLATB ** LIDIMYCIN a> ** BTABONATB ** LINAROTBNB ** ETHYL DIRAZBPATB ** LINTOPRIDB ** BTHYL LOFLAZBPATB ** LIRANAFTATB ** BTONOGBSTRBL ** LITOXBTINB ** BXBMBSTANB ** LOBAPLATIN ** FANTOFARONB ** LOMUSTINB ** FARNBSIL ** LOTBPRBDNOL •• FASUDIL ** LOFBNURON •• FBNDIZOATB ** LUFIRONIL •• PLBROBUTBROL 3001.20 LUTRBLIN •• FLOSATIDIL 3001.20 LYPRBSSIN •• FLOAZURON * L-AMINOACID •• GADOBBNIC ACID ** MABOPROFBN •• GALOCITABINB ** MACROSALB (131 I) •• GANIRBLIX ** MACRO SALB (99m Tc) •• HIBBNZATB •• MARBOFLOXACIN •• HYCLATB ** MBGALLATB ** HYDROTALCITB •• MBLARSOMINB 2928.00 HYDROXYCARBAMIDB ** MBSILATB 2916.19 ICOSAPBNT ** MBTBMBONATB ** IRINOTBCAN ** MBTILSOLFATB ** ISBTIONATB 3001.20 MBTKBFAMIDB ** ISOPHANB INSULIN ** MINAMBSTANB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
•• MIPRAGOSIDB 2934.90 NUCLOTIXBNB •• MIRIMOSTIM 2934.90 NUFENOXOLB •• MIZOLASTINB 2933.90 NUVBNZBPINB •• MODIPAFANT 2941.90 NY STAT IN •• MOFBTIL 2933.39 OBIDOXIMB CHLORIDB •• MOFBZOLAC •• OCAPERIDONB •• MOLGRAMOSTIM 2933.39 OCFENTANIL •• MOSAPRAMINB 2934.90 OCILTIDE 3001.20 MURODBRMIN 3507.90 OCRASB 3002.10 MUROMONAB-CD3 2926.90 OCRILATE •• NADIFLOXACIN 2914 .so OCTABENZONB •• NADROPARIN CALCIUM 2924.29 OCTACAINB \0 •• NAFAGRBL 2923.90 OCTAFONIUM CHLORIDB 2922.50 NAFARBLIN 2928.00 OCTAMOXIN •• NAGLIVAN 2921.19 OCTAMYLAMINB •• NAPADISILATB 2915.90 OCTANOIC ACID •• NAPSILATB 2933.39 OCTAPINOL •• NBFIRACBTAM 2933.90 OCTASTINB •• NBSTIFYLLINB 2939.90 OCTATROPINB MBTHYLBROMIDE 3002.90 NIFUNGIN 2933.40 OCTAVBRINB 3001.20 NORLBUSACTIDB 2934.90 OCTAZAMIDB 2933.90 NORLBVORPHANOL 2933.39 OCTBNIDINB 2922.30 NORMBTHADONB •• OCTIL 2934.90 NORMORPHINB 2933.29 OCT I MI BATE 2933.39 NORPIPANONB 2926.90 OCTOCRILBNB 2933.90 NORTBTRAZBPAM 2921.19 OCTODRINB 2921.49 NORTRIPTYLINB 2922.21 OCTOPAMINB 2914 .49 NORVINISTBRONB 2933.59 OCTOTIAMINB 2933.90 NOSANTINB 2909.49 OCTOXINOL 2934.90 NOSCAPINB •• OCTRBOTIDE 2934.90 NOSIHBPTIDE 2921.49 OCTRIPTYLINB 2932.90 NOVOBIOCIN 2933.90 OCTRIZOLE 2928.00 NOXIPTILINE 2934 .90 OFLOXACIN 2930.90. NOXYTIOLIN 2933.39 OFORNINB 2934.90 NUCLOMBDONB 2932.90 OFTASCEINB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq __ INN __. __Subheadin_q INN
2925.20 OLAFLUR 2932.19 ORPANOXIN •• OLAMINB 2922.19 ORPHBNADRINB 2933.90 OLAQUIRDOX 2921.49 ORTBTAMINB 2932.90 OLKANDOMYCIN 2924.29 OSALMID 2925.20 OLBTIK>L. 2930.90 OSMADIZONB 29tl.90 OLIVOMYCIN 2941.20 OSTRBOGRYCIN 2932.90 OLMIDINB 2933.90 OTBNZBPAD 2934 .90 OLPIMBDONB 2924.29 OTILONIUM BROMIDB 2927.00 OLSALAZINB 2934.90 OTIMBRATB SODIUM 2934.90 OLTIPRAZ 3502 .·90 OVANDROTONB ALBUMIN 2924.29 OLVANIL 2920.90 OXABOLONB CIPIONATB ... 2933.39 OMBPRAZOLB 2921.49 OXABRBXINB 0 · 2933. ~o OMIDOLINB 2933.90 OXACBPROL 2933. 29 OMOCONAZOLB ... 2934.90 OXACILLIN 2934.10 OMONASTBINB 2934 .90 OXADIMBDINB 2922.50 ONAPRISTONB 2934.90 OXAFLOZANB 2933.90 ONDANSBTRON 2934.90 OXAFLUMAZINB 2930.90 ONTIANIL 2933.90 OXAGRBLATB 2933.39 OPINIAZIDB 2918.30 OXALINAST 2933.90 OPIPRAMOL 2934.90 OXALIPLATIN 2933.90 ORAZAMIDB 2932.90 OXAMARIN 2933.90 ORBUTOPRIL 2933.90 OXAMBTACIN 2922.50 ORCIPRBNALINB 2933.90 OXAMISOLB 2933.29 ORCONAZOLB 2933.40 OXAMNIQOINB 2916.39 ORBSTRATB 2924.10 OXANAMIDB ** ORGOTBIN 2937.99 OXANDROLONB 2932.90 ORLIPASTAT 2933.59 OXANTBL 2931.50 ORMAPLATIN 2934 .90 OXAPADOL 2933.59 ORMBTOPRIM 2934.90 OXAPIUM IODIDB 2933.29 ORNIDAZOLB 2932.90 OXAPROPANIUM IODIDB 2933.90 ORNIPRBSSIN 2922.19 OXAPROTILINB 2921.29 ORNITHINB 2934 .90 OXAPROZIN 2918.90 ORNOPROSTIL 2933.90 OXARBAZOLB 2933.59 OROTIC ACID 2933.90 OXATOMIDB 2933.59 OROTIRBLIN 2924.29 OXAZAFONB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinct INN subheadinq______INN____ _. _.
2933.90 OXAZBPAM 2924.29 OXITRIPTYLINB 2934. 90 OXAZIDIONB 2934.90 OXITROPIUM BROMIDE 2934.90 OXAZOLAM 2934.90 OXMETIDINB 2934.90 OXAZORONB 2934.90 OXODIPINB 2933.90 OXCARBAZBPINB 2918.30 OXOGESTONB 2933.90 OXDRALAZINB ** OXOGLURATB 2922.50 OXBLADIN 2934.90 OXOLAMINB 2914 .49 OXBNDOLONB 2934.90 OXOLINICACID 2932.90 OXBPINAC 2934.90 OXOMBMAZINB 2924.29 OXETACAINB 2933.69 OXONAZINB 2934.90 OXETACILLIN 2931.00 OXOPHENARSINB 2932.?0 OXETORONB 2914. 50 OXOPROSTOL .... 2933. 90 OXFBNDAZOLE 2933.39 OXPHBNBRIDINB 2922.50 OXFENICINB 2918.90 OXPRENOATB POTASSIUM 2933.90 OXIBENDAZOLB 2922.50 OXPRENOLOL 2923.90 OXIBBTAINB 2914.50 OXYBBNZONB 2933.29 OXICONAZOLE 2922.50 OXYBUPROCAINB 2922.19 OXIDOPAMINB 2922.50 OXYBUTYNIN 2931.00 OXIDRONIC ACID 2933.40 OXYCINCHOPHEN 2922.50 OXIPBNTOREX 2933.39 OXYCLIPINB 2933.90 OXIFUNGIN 2924.39 OXYCLOZANIDE ** OXIGLtn'ATIONB 2934.90 OXYCODONB 2922 .19' OXILOPRINB 2923.90 OXYDIPBNTONIUM CHLORIDE 2933.90 OXIIIJRPHAN 2922.50 OXYPBDRINB 2934.90 OXIMONAM 2924.29 OXYPBNAMATB 2918.90 OXINDANAC 2914 .49 OXYMBSTBRONB 2933.39 OXINIACIC ACID 2933.29 OXYMBTAZOLINB 2933.90 OXIPBROMIDB 2937.99 OXYMBTHOLONB 2933.90 OXIPURINOL 2934 .90 OXYMORPHONB 2933.90 ox:::RACBTAM 2934.90 OXYPENDYL 2933.39 OXIRAMIDB 2933.59 OXYPBRTINB 2914 .49 OXISOPRBD 2933.19 OXYPHBNBtn'AZONB 2933.39 OXISURAN 2933.59 OXYPHBNCYCLIMINB 2934.90 OXITBFONIUM BROMIDE 2933.79 OXYPHBNISATINB .. a'2'2 an n.VT'T'DTD'T'Jl.U 2q2~ qn OXYPHRNONIUM BROMIDR Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadincr INN______aubhe_adincr INN
2933.90 OXYPYRRONIUM BROMIDE 2925.19 PARAROSANILINE BMBONATB 2934.30 OXYRIDAZINB 2934.30 PARATHIAZINB 2930.90 OXYSONIUM IODIDB 2934.90 PARAXAZONE 2941.30 OXYTBTRACYCLINB 2933.90 PARBBNDAZOLB 2937.99 OXYTOCIN •• PARCBTASAL 2933.29 OZAGRBL 2934 .90 PARCONAZOLB 2934.10 OZOLINONB 2933.90 PARBPTIDB 2926.90 PACRJNOLOL 2922.SO PARBTHOXYCAINB 2922.49 PADIMATB 2922.SO PARGBVBRINB 2924.21 PAFENOLOL 2922.SO PARGOLOL 2933.69 PALATRIGINB 2921.49 PARGYLINB 2941.20 PALDIMYCIN 2933.39 PARIDOCAINE .... 2924.10 PALMIDROL 3001.90 PARNAPARIN SODIUM "' 2932.90 PALMOXIRIC ACID 2933.90 PARODILOL •• PALONIDIPINB 2941.20 PAROMOMYCIN 2933.40 PAMAQUINB 2934.90 PAROXBTINB 2922.SO PAMATOLOL 2914 .so PAROXYPROPIONB 2931.00 PAMIDRONIC ACID 2924.29 PARSALMIDB 2934.90 PANADIPLON •• PARTRICIN 2933.39 PANCOPRIDB 2914. 69 PARVAQUONB 2933.39 PANCURONIUM BROMIDB 2933.39 PASINIAZID 2933.39 PANIDAZOLB 2941.20 PAULOMYCIN •• PANIPBNBM 2922.19 PAXAMATB . 2922 .so. PANOMIFENB 2933.90 PAZELLIPTINB 2933.33 PANTENICATB 2934.90 PAZOXIDB 2936.29 PANTHBNOL 2934.30 PECAZINB 2933.90 PANTOPRAZOLB 2941.90 PECILOCIN 2933.39 PANURAMINB 2941.30 PECOCYCLINB 2933.40 PAPAVBROLINB 2933.59 PEFLOXACIN 2924.29 PARACETAMOL •• PBGADBMASB 2934.90 PARAFLtn'IZIDE •• PBGASPARGASB 2934.90 PARAMBTHADIONB 3907.60 PBGOTBRATB 2918.90 PARAMETHASONE 2933.90 PBLANSBRIN 2933.3~ PARAPENZOLATB BROMIDE 2941.90 PBLIOMYCIN 2924.29 PARAPROPAMOL 2916.39 PELRETIN Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their cor~esponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq _ INH subheading INN
2933.59 PBLRINONB 2933.39 PBNTAZOCINB 2934.90 PBMBDOLAC 2922.42 PENTBTIC ACID 2933.39 PBMBRID 2933.90 PBNTBTRAZOL ** PBMIROLAST ** PBNTBXIL 2934.90 PBMOLINB 2932.90 PBNTHRICHLORAL 2933.39 PBMPIDINB 2934.90 PBNTIAPINB 2941.10 PBNAMBCILLIN 2939.90 PBNTIFYLLINB 2922.50 PBNBtrl'OLOL 2933.90 PBNTIGBTIDB ** PBNCICLOVIR 2941.90 PBNTISOMICIN 2924.10 PBNDBCAMAINB 2933.39 PBNTISOMIDB 2933.39 PBNFLURIDOL 2934.90 PBNTIZIDONB 2935.00 PBNFLUTIZIDB 2933.51 PBNTOBARBITAL ..... w 2938.90 PBNGITOXIN 2933.90 PBNTOLONIUM TARTRATB 2930.90 PBNICILLAMINB 2932.90 PBNTOMONB 3507.90 PBNICILLINASB 2933.90 PBNTOPRIL 2941.30 PBNIMBPICYCLINB 2921.49 PBNTORBX 29-11.30 PBNIMOCYCLINB 3913.90 PBNTOSAN POLYSULFATB SODIUM 2926.90 PBNIROLOL 2934.90 PBNTOSTATIN 2937.99 PBNMBSTBROL 2939.90 PBNTOXIFYLLINB 2923.90 PBNOCTONIUM BROMIDB 2922.50 PBNTOXYVBRINB 2918.90 PBNPROSTBNB 2920.90 -PBNTRINITROL 292-1.10 PBNTABAMATB 2934 .10 PBPLOMYCIN 293-1.90 PBNTACYNIUM CHLORIDB 2924.10 PBPSTATIN 2920.90 PBNTABRITHRITYL TBTRANITRATB 2933.59 PBRACLOPONB 2908.10 PBNTAFLURANOL 2933.59 PBRADOXIMB 2933.90 PBNTAGASTRIN 2933.59 PBRAFBNSINB 2937.92 PBNTAGBSTRONB 2934.90 PBRALOPRIDB 2924.29 PBNTALAMIDB 2933.59 PBRAQUINSIN 2923.90 PBNTAMBTHONIUM BROMIDB 2933.39 PBRASTINB 2925.20 PBNTAMIDINB 2934.10 PBRATIZOLB ** PBNTAMORPHONB 2939.50 PBRBUFYLLINB 2932.90 PBNTAMOXANB 2921.19 PBRFLUAMINB 2933.39 PBNTAPIPBRIDB 2903.59 PBRFLUNAFBNB 2933.39 PBNTAPIPBRIUM MBTILSULFATB ** PBRFOMBDIL ?a':t':t .i.n D'IZN'l'UOTTTNR 2939.60 PBRGOLIDB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN sµbheading INN
2933.39 PBRHBXILINB 2933.90 PHBNINDAMINB 2934.30 PBRICIAZINB 2914 .30 PHBNINDIONB 293 ... 30 PBRIMBTAZINB 2918 .29 PHBNIODOL SODIUM 2933.90 PBRINDOPRIL 2928.00 PHBNIPRAZINB 2933.90 PBRINDOPRILAT 2933.39 PHBNIRAMINB 293 ... 90 PBRISOXAL 2934.90 PHBNMBTRAZINB 2933.59 PBRLAPINB 2933.51 PHBNOBARBITAL 2916.20 PBRMBnlRIN 2933.51 PHBNOBARBITAL SODIUM 293 ... 30 PBRPHBNAZINB 2918. 90 PHBNOBUTIODIL 2908.20 PBRSILIC ACID 2932.29 PHBNOLPHTHALBIN 2933.39 PBTHIDINB 2933.90 PHBNOMORPHAN 2909.49 PBTRICHLORAL 2933.39 PHBNOPBRIDINB ... 2933 .59 PBXANTBL 2934.30 PHBNOTHIAZINB 2933.90 PHANQUINONB 2916.20 PHBN0'111RIN 2925.20 PHBNACAINB 2922.19 PHBNOXYBBNZAMINB 2924.29 PHBNACBMIDB 2941.10 PHBNOXYMBTHYLPBNICILLIN 2924.29 PHBNACBTIN 2924.29 PHBNPROBAMATB 2939.90 PHBNACTROPINIUM CHLORIDB 2932.29 PHBNPROCOtJMON 2934.90 PHBNADOXONB 2921.49 PHBNPROMBTHAMINB 2906.29 PHBNAGLYCODOL 2925.19 PHBNSUXIMIDB 2933.29 PHBNAMAZOLINB 2921.49 PHBNTBRMINB 2933.39 PHBNAMPROMIDB 2933.29 PHBNTOLAMINB 2931.00 PHBNARSONB SULFOXYLATB 2922.49 PHBNYLALANINB 2933.90 PHBNAZOCINB 2933.19 PHBNYLBtn'AZONB 2933.11 PHBNAZONB 2922.50 PHBNYLBPHRINB 2933.39 PHBNAZOPYRIDINB 2931.00 PHBNYLMBRCURIC BORATB 2933.39 PHBNCYCLIDINB 2922.19 PHBNYLPROPANOLAMINB 2934.90 PHBNDIMBTRAZINB 2922.19 PHBNYLTOLOXAMINB 2928.00 PHBNBLZINB 2941.10 PHBNYRACILLIN 2933.39 PHBNBRIDINB 2943.90 PHBNYTHILONB 2941.10 PHBNBTICILLIN 2933.21 PHBNYTOIN 2924.29 PHBNBTURIDB 2933.51 PHBTHARBITAL 2925.20 PHBNFORMIN 2939.10 PHOLCODINB 2925.19 PHBNGLUTARIMIDB 2922.29 PHOLBDRINB 2928.00 PHBNICARBAZIDB 2928.00 PHOXIM Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their cor~esponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (••) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinQ ___IBN subheading INN
2935.00 PHTHALYLSULFAMBTHIZOLB 2939.50 PIMBFYLLINB 2935.00 PHTHALYLSULFATHIAZOLB 2924.10 PIMBLAUTIDB 2936.29 PHYTOMBNADIONB 2933.39 PIMBTACIN 2936.29 PHYTONADIOL SODIUM DIPHOSPHATB 2934.90 PIMBTHIXBNB •• PIBAXIZINB 2933.39 PIMBTINB 2918.30 PIBBCARB 2933.39 PIMBTRBMIDB 2933.59 PIBBRALINB 2933.39 PIMINODINB 2933.39 PICAFIBRATB 2933.90 PIMOBBNDAN 2934.90 PICART.AMIDS 2933.90 PIMONIDAZOLB 2933.39 PICBNADOL 2933~39 PIMOZIDB 2933.90 PICILORBX 2933.39 PINACIDIL 2934.90 PICLONIDINB 2934.90 PINADOLI~ ...... l.n 2933.59 PICLOPASTINB 2933.90 PINAFIDB 2933.59 PICLOXYDINB ... 2934.90 PINAVBRIUM BROMIDB 2933.39 PICOBBNZIDB 2933.90 PINAZBP.AM 2933.39 PICODRALAZINB 2933.90 PINCAINIDB 2933.39 PICOLAMINB 2933.90 PINDOLOL 2933.39 PICONOL 2933.39 PINOLCAINB 2933.39 PICOPBRINB 2934.90 PINOXBPIN 2933.39 PICOPRAZOLB 2934.90 PIOGLITAZONB 2933.39 PICOTRIN 2941.30 PIPACYCLINB 2934.90 PICCMAST 2934.30 PIPAMAZINB •• PICUMBTBROL 2933.39 PIP.AMPBRONB •• PIDOLACBTAMOL 2934.90 PIPAZBTATB 2933.79 PIDOLIC ACID 2933.59 PIPBBUZONB •• PIDOTIMOD 2933.59 PIPBCURONIUM BROMIDB 2934.90 PIFARNINB 2933.59 PIPBMIDIC ACID 2933.39 PIFBNATB 2933.39 PIPBNZOLATB BROMIDB 2934.90 PIFBXOLB 2933.59 PIPBQUALINB 2934.90 PIFLUTIXOL 2934.30 PIPBRACBTAZINB 2933.39 PIFOXIMB 2941.10 PIPBRACILLIN 2933.39 PIKBTOPROFBN 2933.59 PIPBRAMIDB 2933.90 PILDRALAZINB 2933.59 PIPBRAZINB CALCIUM BDBTATB •• PILSICAINIDE 2933.39 PIPERIDOLATB ?Q':t':t ':tQ DTMlU"TLlNR 2933.39 PIPEROCAINB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadiruL___ ... INN subheadinq INN
2934.90 PIPBROXAN 2933.39 PIRFBNIDONB 2933.39 PIPBRYLONB 2933.59 PIRIBBDIL 2933.39 PIPBTHANATB 2941.10 PIRIDICILLIN 2933.59 PIPOBROMAH 2933.39 PIRIDOCAINB 2933.39 PIPOCTANONB 2933.39 PIRIDOXILATB 2934.90 PIPOFBZINB 2933.39 PIRIDRONIC ACID 2933.59 PIPOSOLFAN 2933.39 PIRIFIBRATB 2935.00 PIPOTIAZINB 2933.39 PIRINIDAZOLB "2933.39 PIPOXIZINB 2933.59 PIRINIXIC ACID 2934.90 PIPOXOLAN 2933.59 PIRINIXIL 2933.39 PIPRADIMADOL 2933.59 PI RI PROST ... 2933.39 PIPRADROL 2933.59 PIRIQUALONB 0\ 2933 .·39 PIPRAMADOL 2933.39 PIRISUDANOL 2933. 59 PIPRATBCOL 2933.39 PIRITRAMIDB r 2939.50 PIPRINHYDRINATB 2933.59 PIRITRBXIM 2933.39 PIPROCORARIUM IODIDE 2941.90 PIRLIMYCIN 293t.90 PIPROFUROL 2933.59 PIRLINDOLB 2934.10 PIPROZOLIN 2933.90 PIRMAGRBL 2933.90 PIQUINDONB 2933.39 PIRMBNOL 2933.59 PIQUIZIL 2932.90 PIRNABIN .2933. 79 PIRACBTAM 2933.79 PIROC'l'ONB 2932.90 PIRANDAMINB 2933.39 PIRODAVIR 2934.90 PIRARUBICIN ** PIRODOMAST 2933.79 PIRAXBLATB 2933.90 PIROOLIRIDB 2934.90 PIRAZMONAM 2933.90 PIROHBPTINB 2934.90 PIRAZOFURIN 2933.59 PIROLATB 2933.19 PIRAZOLAC 2933.59 PIROLAZAMIDB 2941.10 PIRBBNICILLIN 2933.59 PIROMIDIC ACID 2933.39 PIRBUTBROL 2933.90 PIROXANTRONB 2933.39 PIRDONIUM BROMIDE 2934.90 PI ROXI CAM 2934.90 PIRENOXINB 2941.10 PIROXICILLIN 2933.59 PIRBNPBRONB 2933 .39 PIROXIMONB 2933.59 PIRBNZBPINB 2933.39 PIROZADIL 2933.59 PIRBPOLOL 2933.90 PIRPROFBN 2933.79 PIRBTANIDB 2933.59 PIRQUINOZOl. Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World! Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2933.90 PIRRALKONIUM BROMIDB 2937.92 POLYBSTRADIOL PHOSPHATE ** PIRSIDOMINB 3907.30 POLYBTADBNB 2933.39 PIRTBNIDINB 3913.90 POLYGBLINB 2934.90 PITBNODIL 3907.99 POLYGLYCOLIC ACID 2933.39 PITOFBNONB 2941.90 POLYMYXIN B 2933.39 PITUXATB 3909.10 POLYNOXYLIN * PIVALATB 3907.20 POLYSORBATB 2941.10 PIVAMPICILLIN 2935.00 POLYTHIAZIDB 2922.50 PIVBNFRINB 3905.90 POLYVIDONB 2941.10 PIVMBCILLINAM 2934.90 PONALRBSTAT 2930.90 PIVOPRIL 2932.90 PONFIBRATB 2933.90 PIVOXAZBPAM i 2933.90 PORFIMBR SODIUM ... 2941.90 PORFIROMYCIN ...J * PIVOXBTIL * PIVOXIL 2933.59 POSATIRBLIN 2934.90 PIZOTIFBN 2935.00 POSKINB 2934.90 PLAFIBRIDE 2918.90 POTASSIUM CANRBNOATB 2905.39 PLAUNOTOL 2918 .16 POTASSIUM GLUCALDRATE 2941.90 PLAURACIN 2933.90 POTASSIUM NITRAZEPATE 2918.19 PLBUROMULIN 2924.29 PRACTOLOL 2941.20 PLICAMYCIN 2939.90 PRAJMALIUM BITARTRATB 2934.10 PODILFBN 2933.39 PRALIDOXIMB IODIDE 39U.OO POLACRILIN 2934.30 PRAMIPEXOLE 2933.90 POLDINB MBTILSULFATE 2933.90 PRAMIRACETAM 3908.10 POLICAPRAM 2921.49 PRAMIVBRINB 3911.90 POLICRBSULBN 2934.90 PRAMOCAINB 3913.90 POLIDBXIDB SULFATE 2939.90 PRAMPINB ** POLIFEPROSAN 2923.90 PRANOLIUM CHLORIDE 2913.00 POLIGBBNAN 2934.90 PRANOPROFEN 3911.90 POLIHEXANIDE 2933.90 PRANOSAL 2938.90 POLISAPONIN 2937.99 PRASTERONB 3904.61 POLITBF 2934.90 PRAVADOLINB 3907.20 POLOXALBNB 2932.29 PRAVASTATIN 3907.20 POLOXAMBR 2933.19 PRAX.ADINB 3907.10 POLYBENZARSOL 2933.90 PRAZBPAM 3906.90 POLYCARBOPHIL 2933.90 PRAZBPINB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural inforir.atlon was not available at time of classification or description is too general to classify.)
HTS HTS
subheadinq rn -H-- n INN ___subhejljjinq INN
2933.59 PRAZIQUARTBL 2933.59 PRIMIDONB 2933.51 PRAZITORB 2941.90 PRIMYCIN 29tl.10 PRAZOCILLIN 2933.90 PRINOMIDB 293t.90 PRAZOSIN 2933.39 PRINOXODAN 2933.39 PRBCLNllL 2933.39 PRISOTINOL 2937.29 PRBDNAZATB 2941.90 PRISTINAMYCIN 2937.29 PRBDNAZOLINB 2933.90 PRIZIDILOL 2937.29 PRBDNICARBATB 2922.19 PROADIFBN 2937.29 PRBDNIMUSTINB 2933.51 PROBARBITAL SODIUM 2937.29 PRBDNISOLAMATB 2935.00 PROBBNBCID 2937.21 PRBDNISOLONB 2930.90 PROBUCOL I ... 2937.29 PRBDNISOLONB STBAGLATB I 2924.29 PROCAINAMIDB CD 2937.21 PRBDNISONB 2924.29 PROCAINB 2937.29 PRBDNYLIDBNB 2928.00 PROCARBAZINB 2922.49 PRBFBNAMATB 2933.79 PROCATBROL 2937.29 PRBGNBNOLONB 2934.30 PROCHLORPBRAZINB 2933.90 PRBMAZBPAM 2922.50 PROCINOLOL 2922.50 PRBNALTBROL 2937.29 PROCINONIDB 2930.90 PRBNISTBINB 2906.29 PROCLONOL 2922.19 PRBNOVBRINB 2933.90 PROCODAZOLB 2933.39 PRBNOXDIAZINB 2933.90 PROCYCLIDINB 2921.t9 PRBNYLAMINB 2924.29 PROCYMATB 293t.10 PRBTAMAZIUM IODIDB 2923.90 PRODBCONIUM BROMIDB 2935.00 PRBTIADIL 2933.90 PRODILIDINB 2933.39 PRIBBCAINB 2933.39 PRODIPINB 2933.90 PRIDBFINB 2934.90 PRODOLIC ACID 2933.39 PRIDBPBRORB 2933.90 PROFADOL 2933.39 PRIDINOL 2934.30 PROFBNAMIRB 2934.90 PRIFBLORB 2934 .90 PROFBXALONB 2933.90 PRIFINIOM BROMIDB 2933.90 PROFLAVINB 2934.90 PRIFUROLINB 2933.90 PROFLAZBPAM 2924.29 PRILOCAINB 2924.29 PROOABIDB 2933.39 PRIMAPBRONB 2937.92 PROGBSTBRONB 2933.40 PRIMAQUINB 2933.59 PROGLUMBTACIN 2911_59 PRIMIDOLOL 2924.29 PROOLUMIDR • '. . Table. 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinct INN__ subheadinq INN
2925.20 PROOUANIL 2933.39 PROP I RAM 2933.90 PROHBPTAZINB 2936.60 PROPISBRGIDB 2932.90 PROLIGBSTONB 2933.39 PROPIVBRINB 2933.90 PROLINB 2933.90 PROPIZBPINB 2933.90 PROLINTANB 2907.19 PROPOFOL 2923.90 PROLONIUM IODIDB 2933.29 PROPOXATB 2934.30 PROMAZINB 2924.29 PROPOXYCAINB 2937.92 PROMBGBSTONB 2922.50 PROPRANOLOL 3507.90 PROMBLASB 2918.30 PROPYL DOCBTRIZOATE 2909.30 PROMBSTRIBNB 2921.30 PROPYLHBXBDRINB 2934.30 PROMBTHAZINB 2933.39 PROPYLIODONB ... 2934.30 PROMBTHAZINB TBOCLATB 2933.59 PROPYLTHIOURACIL \0 2934.90 PROMOLATB 2933.39 PROPYPBRONB 2932.90 PROMOXOLANB 2933 .11 PROPYPHENAZONB 2922.19 PRONBTALOL 2934.30 PROPYROMAZINB BROMIDB 2924.29 PROPACBTAMOL 2933.59 PROQUAZONB 2922.50 PROPAFBNONB 2933.40 PROQOINOLATB 3907.99 PROPAGBRMANIUM 2937.92 PRORBNOATB POTASSIUM 2925.20 PROPAMIDINB 2934 .90 PROROXAN 2924.29 PROPANIDID 2938.90 PROSCILLARIDIN 2922.19 PROPANOCAINB 2933.59 PROSPIDIUM CHLORIDB 2932.90 PROPANTHBLINB BROMIDB 2918.19 PROSTALBNB 2920.90 PROPATYLNITRATB 2935.00 PROSULPRIDB 2935.00 PROPAZOLAMIDB 2933.59 PROSULTIAMINB 2933.29 PROPBNIDAZOLB 3504.00 PROTAMINB SULFATE 2939 .. 50 PROPBNTOFYLLINB 3004.31 PROTAMINB ZINC INSULIN 2933.39 PROPBRIDINB INJECTION 2924.29 PROPBTAMIDB - 2933.90 PROTBRGORIDB 2937.92 PROPBTANDROL 2939.90 PROTHBOBROMINB 2941.10 PROPICILLIN 2934.90 PROTHIPBNDYL 2941.20 PROPIKACIN 2934.90 PROTHIXBNB 2933.39 PROPINBTIDINB 2934.90 PROTIOFATB 2932.29 PROPIOLACTONB 2933.39 PROTIONAMIDB 2934.30 PROPIOMAZINE 2937.10 PROTIRBLIN 2Q'l'l 'lQ PROPIPOCAINE 2934.30 PROTIZINIC ACID Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups p~oposed by the World Health Organization. Two asterisks (••) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2932.90 PROO'OKYLOL 2933.90 PYRROLIFBNB 2921.49 PROTRIPTYLIRB 2941.90 PYRROLNITRIN 2934.90 PROXAZOLB 2933.40 PYRVINIUM CHLORIDB •• PROXBTIL 2933.39 PYTAMINB 2933.51 PROXIBARBAL 2933.90 QUADAZOCINB 2922.19 PROXIBOTBRB 2931. 00 QOADROSILAN 2932.90 PROXICROMIL 2924.29 QUATACAINB 2933.19 PROXIFBZORB 2933.39 QUAZBPAM 2934.90 PROXORPHAN 2933.59 QUAZINONB 2922.50 PROXYMBTACAIRB 2933.59 QUAZODIRB 2939.50 PROXYPHYLLINB 2933.90 QUAZOLAST 2933. 90 PROZAPINB 2933.90 QUIFBNADINJi 2939.40 PSBUDOBPHBDRINB 2933.90 QUILLIFOLINB 0"' 2933 .90 PSILOCYBIRB r·. 2933.39 QUINACAINOL 2933. 59 PUMITBPA 2941.10 QUINACILLIN 2941.90 PUROMYCIN 2933.90 QUINAOOLIDB 2934.90 PYRANTBL 2933.40 QUINALDIRB BLOB 2933.90 PYRAZINAMIDB 2933.40 QUINAPRIL 2933.39 PYRICARBATB 2933.40 QUINAPRILAT 2934.90 PYRIDARONB 2933.90 QUINAZOSIN 2939.50 PYRIDOFYLLINB 2914 .so QUINBOLONB 2933.39 PYRIDOSTIGMINB BROMIDB 2934.90 QUINCARBATB 2933.39 PYRIDOXINB 2933.40 QUINDBCAMINB 2933.59 PYRIMBTHAMINB 2933.90 QUINDONIUM BROMIDB 2933.59 PYRIMITATB 2933.90 QUINDOXIN 2933.39 PYRINOLINB 2933.90 QUINBLORANB 2933.39 PYRITHIONB ZINC 2937.92 QUINBSTRADOL 2933.39 PYRITHYLDIONB 2937.92 QUINBSTROL 2933.59 PYRITIDIUM BROMIDB 2933.40 QUINBTALATB 2933.39 PYRITINOL 2935.00 QUINBTHAZONB 2933. 90 PYROPHBNDANB 2933.90 QUINBZAMIDB 2933.90 PYROVALBRONB 2934.90 QUINFAMIDB 2933.90 PYROXAMINB 2937.92 QUINGBSTANOL 3912.20 PYROXYLIN 2937.92 QUINGBSTRONE 2933.90 PYRROCAINB 2933.40 OUINISOCAIN'E . Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their co;responding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2933.40 QUINOCIDB 2934.90 RAZINODIL ** QUINOTOLAST 2933.79 RAZOBAZAM 2933.90 QUINPIROLB 2933.59 RAZOXANB 2933.40 QUINPRBNALINB 2933.40 RBBAMIPIDB 2933 .40 QUINTIOPOS 2934.90 RBBOXBTINB 2933.39 QUINOCLIUM BROMIDE 2921.51 RB CAI NAM 2933.39 QUINOPRAMINB 2934.90 RBCLAZBPAM ** QUINOPRISTIN 3001.20 RBGRAMOSTIM 2933.59 QUIPAZINB 2941.90 ULOMYCIN 2934.30 QUISUL'l'AZINB 2922.30 RBMACBMIDB 2922.19 RACBFBMINB ** RBMIPROSTOL .., 2941.40 RACBFBNICOL 2933.90 RBMOXIPRIDB ...... 2906 .11 RACBMBNTHOL 2914 .49 RB NANO LO NB 2933.fiO RACBMBTHORPHAN 2934 .10 RBNTIAPRIL 2922.50 RACBMBTIROSINB 2925.10 RBNYTOLINB 2934 .90 RACBMORAMIDB 2933.90 RBNZAPRIDB 2933.40 RACBMORPHAN 3907.20 RBPAGBRMANIUM 2937.99 RACBPINBFRINB ** RBPAGLINIDB 2933.90 RACLOPRIDB 2934 .90 RBPIRINAST 2922.29 RACTOPAMINB 2941.90 RBPROMICIN 2924.29 RAFOXANIDB 2939.50 RBPROTBROL 2934.10 RALITOLINB 2933.90 RBSCIMBTOL 2934.90 RALOXIFBNB 2939.90 RBSCINNAMINB 2921.49 RAMCICLANB 2939.90 RBSBRPINB 2933.19 RAMIFBNAZONB 2924.29 RBSORANTBL 2933.90 RAMIPRIL 2934.90 RBTBLLIPTINB 2933.90 RAMIPRILAT 2936.21 RBTINOL 2932.19 RAMIXOTIDINB 2933.59 RBVBNAST 2932.29 RAMNODIGIN ** RBVIPARIN SODIUM 2941.90 RP.MOPLANIN 2934.90 RBVOSPIRONB 2932.90 RANIMUSTINB 2933.59 RIBAMINOL 2941.90 RANIMYCIN 2934.90 RIBAVIRIN 2932.19 RANITIDINB 2936.23 RIBOFLAVIN· 2933.59 RANOLAZINB 2934.90 RIBCPRINB 2922.50 RATHYRONINB 294.1.90 RIBOSTAMYCIN Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadina INN__ subheadina INN
2933.90 RIDAZOLOL 2935.00 RITOLUICAST 2933.39 RIDOORBL 2933.39 RITROPIRRONIUM BROMIDB 2933.59 RIFABUTIN 2930.90 RITROSULFAN 2941.90 RIF.AMBTANB ** RIZOLIPASB 2941.90 RIPAMIDB 2928.00 ROBBNIDINB 2941.90 RIPAMPICIN 2934.90 ROCASTINB 2941.90 RIFAMYCIN 2933.90 ROCICLOVIR 2941.90 RIFAPBNTINB 2922.50 ROCIVBRINB 2934.90 RIFAXIMIN 2933.90 RODOCAINB 2933.59 RI LAP I NB 2932.90. RODOROBICIN ** RILMAKALIM 2933.59 ROFBLODINB 2934.90 RILMAZAFONB 2909.19 ROFLORANB llJ llJ 2934.90 RILMBNIDINB ** ROGLBTIMIDB 2933.39 RILOPIROX 2941.90 ROKITAMYCIN 2933.90 RILOZARONB ** ROLAFAGRBL 2934.20 RI LOZO LB 2933.90 ROLBTAMIDB 2921.30 RIMANTADINB 2933.90 ROLGAMIDINB 2933.59 RIMAZOLIUM MBTILSULFATB 2933.90 ROLICYCLIDINB 2933.59 RIMCAZOLB 2933.90 ROLICYPRINB 29U.49 RIMBXOLONB 2933.79 ROLIPRAM 2933.39 RIMITBROL 2941.30 ROLITBTRACYCLINB 2933.59 RIMOPROGIN 2933.59 ROLODINB 2933.39 RIODIPINB 2933.90 ROLZIRACBTAM 29U .49 RIOPROSTIL 2934 .90 ROMAZARIT 2933.90 RIPAZBP~ 2934.90 ROMIFBNONB 2933.39 RISBDRONIC ACID 2933.29 ROMIFIDINB 2922.50 RISOCAINB 2932.90 ROMURTIDB· 2935.00 RISOTILIDB 2912.49 RONACTOLOL 2933.90 RISPBNZBPINB 2933.29 RONIDAZOLB 2934.90 RISPBRIDONB 2933.39 RONIFIBRATB 2933.39 RISTIANOL 2926.9C> RONIPAMIL 2941.90 RISTOCBTIN 2933.90 ROPINIROLB 2934. 90 RITANSBRIN 2933.39 ROPITOIN 2930.90 RITIOMBTAN 2933.39 ROPIVACAINB 2922.50 RITODRINB 2933.59 ROPIZINB· • r' > Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two astf.:i i Aks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadina INN subheadina INN
2933.79 ROQOINIMBX 2924.29 SALFLUVERINB 2918 .19 ROSAPROSTOL 2924.29 SALICYLAMIDB 2941.90 ROSARAMICIN 2933.39 SALINAZID •• ROSB BBNGAL (131 I) SODIUM 2941.90 SALINOMYCIN 2933.40 ROSOXACIN 2922.50 SALMBFAMOL 2937.99 ROSTBROLONB 2922.50 SALMBTBROL 2941.10 ROTAMICILLIN 2922.50 SALMISTBINB 2933.39 ROTOXAMINB 2932.19 SALPROTOSIDB 2922.50 ROTRAXATB 2918.23 SALSALATB 2922.50 ROXADIMATB 2924.29 SALVBRINB 2931.00 ROXARSONB 2933.39 SAMPIRTINB 2933.59 ROXATIDINB 2941.30 SANCYCLINB Ill w 2918 .'90 ROXIBOLONB 2934.90 SAPBRCONAZOLB 2933.90 ROXINDOLB 2933.59 SAPROPTBRIN 2941.50 ROXITHROMYCIN 2933.59 SARAFLOXACIN 2933.90 ROXOLONIUM 2933.29 SARALASIN MBTILSULFATB 2922.49 SARCOLYSIN 2933.39 ROXOPBRONB 2933.90 SARMAZBNIL 2934.90 ROFLOXACIN 2941.10 SARMOXILLIN 2941.90 ROFOCROMOMYCIN 2941.10 SARPICILLIN 2941.90 RUTAMYCIN 2918.90 SARPOORBLATB 2938.10 RtJTOSIDB 3003.90 SAROPLASB 2928.00 ROVAZONB 2933.59 SATBRINONB 2934.20 SABBLOZOLB 2935.00 SATRANIDAZOLB ** SAGANDIPINB 2934.90 SAVIPRAZOLB 2924.29 SALACBTAMIDB 2934.90 SAVOXBPIN 2918.22 SALAFIBRATB 2906.19 SBCALCIFBROL 2924.29 SALANTBL 2933 .51 SBCBUTABARBITAL 2935.00 SALAZODINB 2934.90 SBCLAZONB 2935.00 SALAZOSULFADIMIDINB 2933.29 SBCNIDAZOLB 2935.00 SALAZOSULFAMIDB 2933.51 SBCOBARBITAL 2935.00 SALAZOSULFATHIAZOLB 2922.50 SBCOVBRINB 2922.50 SALBuTAMOL 2937 .-99 SBCRBTIN 2923.10 SALCOLBX 2934.90 SBCURININB 2924.29 SALBTAMIDB 2941 .. 90 SBDECAMYCIN Table. 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2933.59 SBGANSBRIN **· SIFAPRAZINB 2933.90 SBGLITIDB 2933.90 SIGU.AZODAN 2921.49 SBLBGILINB 2937.99 SILANDRONB 28H.40 SBLBNOMBTHIONINB (75 SB) 2932.90 SILIBININ 2933.59 SBLPRAZINB 2932.90 SILICRISTIN 2935.00 SBMATILIDB 2932.90 SILIDIANIN 2941.90 SBMDURAMICIN 2933.90 SILTBNZBPINB •• SBMDTIADIL •• SILTBPLASB 2924.21 SBMUSTINB 2842.10 SIMALDRATB 2933.29 SBPAZONIUM CHLORIDB 2933.59 SIMBTRIDB 2933.39 SBQUIFBNADINB 2918.90 SIMFIBRATB 2937.29 SBRACTIDB 2928.00 SIMI'RAZBNB t.J 2933. 59 SBRAZAPINB 2932.29 SIMVASTATIN "' 2930.90 SBRFIBRATB 2933.90 SINCALIDB 2933.90 SBRGOLBXOLB 2941.90 SINBFUNGIN 2922.50 SBRINB 2939.90 SINTROPIUM BROMIDB 2933.90 SBRMBTACIN 2941.90 SISOMICIN 3001.20 SBRMORBLIN 2933.79 SITALIDONB 3507.90 SBRRAPBPTASB 2918 .90 SITOFIBRATB 2934.90 SBRTACONAZOLB 2940.00 SITOGLUSIDB 2933.39 SBRTINDOLB 3003.90 SIZOFIRAN 2921.45 SBRTRALINB 2933.59 SOBUZOXANB 2937.99 SBRUM GONADOTROPHIN 2924.29 SODIUM ACBTRIZOATB 2933.90 SBTASTINB 2924.29 SODIUM AMIDOTRIZOATB 2922.19 SBTAZINDOL 3901.90 SODIUM APOLATB 2933.90 SBTIPTILINB 2936.27 SODIUM ASCORBATB 2934.90 SBTOPBRONB 2843 .30 SODIUM AUROTHIOMALATB 2934.90 SBVITROPIUM MBSILATB 2843.30 SODIUM AUROTIOSULFATB 2909.19 SBVOFLURANB 2930.90 SODIUM BITIONOLATB 2924.29 SBVOPRAMIDB 2844.40 SODIUM BOROCAPTATB (108) 2935.00 SBZOLAMIDB 2922.49 SODIUM CALCIUM BDBTATB 3507.90 SFBRICASB 2841.30 SODIUM CHROMATB (51 CR) 3001.20 SIAGOSIDB 2929.90 SODIUM CYCLAMATB 2921.49 SIBUTRAMINB 2918.30 SODIUM DBHYDROCHOLATB 2941.90 SICCANIN 2904.10 SODiqM J;>~Bt}NATB I I > Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their co~responding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was no~ available at time of classification or description is too general to classify.)
HTS HTS subheadinq INN subhe_adinq INN
292t.29 SODIUM DIPROTRIZOATB 2937.10 SOMBNOPOR 2920.90 SODIUM BTASULFATB 3001.20 SOMBTRIBOVB 2924.10 SODIUM FBRBDBTATB 3001.20 SOMBTRIPOR 2918.29 SODIUM GBNTISATB 2937.10 SOMIDOBOVB 2918.90 SODIUM GLUCASPALDRATB 2934.30 SOPITAZINB 2~0t.10 SODIUM GUALBNATB 2933.29 SOPROMIDINB 2918 .90 SODIUM HBXACYCLONATB 2933.40 SOQUINOLOL 2844.tO SODIUM IODIDB (125 I) 2923.29 SORBINICATB 2844.40 SODIUM IODIDB (131 I) 2934.90 SORBINIL 2844 .40 SODIUM IODOHIPPURATB (131 I) 3823.90 SORBITAN LAURATB 2924.29 SODIUM IOPODATB 3823.90 SORBITAN OLBATB 2844.40 SODIUM IOTALAMATB (125 I) 3823.90 SORBITAN J?ALMITATB "1 U1 2844 .·40 SODIUM IOTALAMATB (131 I) 3823.90 SORBITAN SBSQUIOLBATB 2924.29 SODIUM MBTRIZOATB ... 3823.90 SORBITAN STBARATB ** SODIUM MORRHUATB 3823.90 SORBITAN TRIOLBATB 2844 .40 SODIUM PHOSPHATE (32 P) 3823.90 SORBITAN TRISTBARATB 2933.39 SODIUM PICOFOSFATB ** SORIWDINB 2933.39 SODIUM PICOSULFATB 2934.90 SORNIDIPINB 2934.90 SODIUM STIBOCAPTATB 2935.00 SOTALOL 29t2.00 SODIUM STIBOOLUCONATB 2935.00 SOTBRBNOL 2920.90 SODIUM TBTRADBCYL SULFATB 2924.10 SPAGLUMIC ACID 2931.00 SODIUM TIMBRFONATB 2933.59 SPARFLOXACIN 292t.29 SODIUM TYROPAHOATB 2931.00 SPARFOSIC ACID 2918.90 SOFALCONB 2941.90 SPARSOMYCIN 2930.90 SOLASULFONB 2939.90 SPARTBINB 2922.50 SOLPBCAINOL 2941.90 SPBCTINOMYCIN 2934.90 SOLYPBRTINB 2934.90 SPICLAMINB 2937.10 SOMAGRBBOVB 2934.30 SPICLOMAZINB 2937.10 SOMALAPOR 2933.39 SPIPBRONB 2921.30 SOMANTADINB 2934.90 SPIRADOLINB 2937.10 SOMATORBLIN 2933.39 SPIRAMIDB 3001.20 SOMATOSTATIN 2941.90 SPIRAMYCIN 2937.10 SOMATRBM 2934.90 SPIRAPRIL 2937.10 SOMATROPIN 2934.90 SPIRAPRILAT 2937.10 SOMAVUBOVR 2933.69 SPIRAZINB Table l··Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq _ ___ INN______subheadincr INN
2922.50 SPIRBNDOLOL 2941.20 STRBPTONIAZID 2933.39 SPIRGBTINB 2941.90 STRBPTOVARYCIN 2933.39 SPIRILBNB 2932.90 STRBPTOZOCIN 2933.29 SPIRIPROSTIL 2933.90 STRINOLINB 2934.90 SPIROPYLLINB 2924.29 STYRAMATB 2934.90 SPIROOBRMANIUM 2930.90 SUBATHIZONB 2933.29 SPIROMUSTINB 2934.90 SUBBNDAZOLB 2932.90 SPIRONOLACTONB 2930.90 SUCCIMBR 2930.90 SPIROPLATIN 2935.00 SUCCINYLSULFATHIAZOLB 2932.29 SPIRORBNONB 2930.90 SUCCISULFONB 2932.19 SPIROXASONB 2935.00 SUCLOFBNIDB 2934.90 SPIROXATRINB 2940.00 SUCRALFATB tJ 0\ 2932 .'90 SPIROXBPIN 2942.00 SUCRALOX 2932.90 SPIZOFURONB 2940.00 SUCROSOFATB 2941.90 STALLIMYCIN 2932.90 SUDBXANOX 2937.99 STANOZOLOL 3001.20 SUDISMASB 2934.90 STAWDINB 2935.00 SUDOXICAM ** STBAGLATB 2934.90 SUFBNTANIL 2935.00 STBARYLSULFAMIDB 2934.90 SUFOSFAMIDB 2941.90 STBPPIMYCIN 2933.39 SUFOTIDINB 2918.90 STBNBOLONB 2933.90 SULAZBPAM 2934.90 STBPRONIN 2933.90 SULAZURIL 2933.90 STBRCURONIUM IODIDB 2934.90 SULBACTAM 2922.19 STBVALADIL 2941.10 SULBBNICILLIN 2931.00 STIBAMINB GLUCOSIDB 2934.90 SULBBNOX 2931.00 STIBOSAMINB 2934.90 SULBBNTINB 2925.20 STILBAMIDINB ISBTIONATB 2933.59 SULBtn'IAMINB 2933.39 STILBAZIUM IODIDB 2935.00 SULCLAMIDB 2923.90 STILONIUM IODIDB 2933.29 SULCONAZOLB 2933.29 STIRIMAZOLB 3001.20 SULBPAROID SODIUM 2932.90 STIRIPBNTOL 2935.00 SULFABBNZ 2928.00 STIROCAINIDB 2935.00 SULFABBNZAMIDB 3507.90 STRBPTODORNASB 2935.00 SULFACARBAMIDB 3507.90 STRBPTOKINASB 2935.00 SULFACBCOLB """'.... "" ~mnDftl'IV'\~,..TU ?Q-:tc:: nn !:!Tn.ll'nrR'l'ZUll!'TnR I I > Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their co~responding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading· INN subheading INN
2935.00 SULPACHLORPYRIDAZINB 2935.00 SULFAPYRAZOLB 2935.00 SULPACHRYSOIDINB 2935.00 SULFAPYRIDINB 2935.00 SULFACITINB 2935.00 SULFAQUINOXALINE 2935.00 SULFACLOMIDB 2931.00 SULFARSPHBNAMINB 2935.00 SULFACLORAZOLB 2935.00 SULFASALAZINB 2935.00 SULPACLOZINB 2935.00 SULFASOMIZOLB 2935.00 SULPADIASULFONB SODIUM 2935.00 SULFASUCCINAMIDB ·2935.00 SULPADIAZINB 2935.00 SULFASYMAZINB 2935.00 SULFADIAZINB SODIUM 2935.00 SULFATHIAZOLE 2935.00 SULFADICRAMIDB 2935.00 SULFATHIOURBA 2935.00 SULFADIMBTHOXINB 2935.00 I SULFATOLAMIDB 2935.00 SULFADIMIDINB 2935.00 SULFATROXAZOLB .., 2935 .'oo SULFADOXINB 2935.00 SULFATROZOLB -.I 2935.00 SULFABTHIDOLB 2930.90 SULFINALOL 2935.00 SULFAFURAZOLB · 2933.19 SULFINPYRAZONB 2935.00 SULFAGUANIDINB 2930.90 SULFIRAM 2935.00 SULFAGUANOLB 2935.00 SULFISOMIDINB 2935.00 SULFALBNB 2909.50 SULFOOAIACOL 2935.00 SULPALOXIC ACID 2941.90 SULFOMYXIN 2935.00 SULFAMAZONB 2930.90. SULPONTBROL 2935.00 SULFAMBRAZINB 2934.30 SULFORIDAZINB 2935.00 SULFAMBRAZINB SODIUM 3001.90 SULGLICOTIDB 2935.00 SULFAMBTHIZOLB 2935.00 SULICRINAT 2935.00 SULFAMBTHOXAZOLB 2930.90 SULINDAC 2935.00 SULFAMBTHOXYPYRIDAZINB 2933.79 SULISATIN 2935.00 SULFAMBTOMIDINB 2914. 70 SULISOBBNZONB 2935.00 SULFAMBTOXYDIAZINB 2932.29 SUI.MARIN 2935.00 SULFAMBTROLB 2933.90 SULMAZOLB 2935.00 SULFAMONOMBTHOXINB 2935.00 SULMBPRIUB 2935.00 SULFAMOXOLB 2933.29 SULNIDAZOLB 2935.00 SULFANILAMIDB 2935.00 SULOCARBILATB 2935.00 SULFANITRAN 2930.90 SULOCTIDIL 2935.00 SULFAPBRIN 2938.90 SULODBXIDB 2935.00 SULFAPHBNAZOLE 2935.00 SULOFENUR 2935.00 SULFAPROXYLINE 2935.00 SULOSEMIDE Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN nanies for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information.was not available at time of classification or description is too general to classify.)
HTS HTS subheadin_q______INN ______subheadinq INN
2935.00 SOLOTROBAH 2939.90 SYROSINGOPINB 2930.90 SULOXIFBN 2924.10 TABILAtn'IDB 2935.00 SULPIRIDB ** TACALCITOL 2918.23 SULPROSAL 2933.90 TACLAMINB 2935.00 SULPROSTONB 2933.90 TACRINB 29'61.10 SULTAMICILLIN 2925.19 TAGLtn'IMIDB 2935.00 SULT IAMB 2941.10 TALAMPICILLIN 2933.90 SULTOPRIDB 2933.90 TALASTINB 2908.20 SULTOSILIC ACID 2933.51 TALBUTAL 2933.39 SULTROPONIUM 2932.29 TALBRAHOL 2933.90 SULUKAST 2924.21 TALINOLOL .., 2935.00 SULVBRAPRIDB 2934.90 TALIPBXOLB CD 2930.90 SUMACBTAMOL 2941.90 TALISOMYCIN 2930.90 SUMAROTBNB 2934.90 TALMBTACIN 2935.00 SUMATRIPTAN 2933.59 TALMBTOPRIM 2935.00 SUMBTIZIDB 2934.90 TALNIFLUMATB 2933.59 SUNAGRBL 2932.90 TALOPRAM 29'61.10 SUNCILLIN 2932.29 TALOSALATB 2935.00 SUPIDIMIDB 2933.90 TALOXIMINB •• SUPLATAST TOSILATB 2934.90 TALSUPRAM 29lt.90 SOPROCLONB 2935.00 TALTRIMIDB 29Jt.90 SOPROFBN 2933.59 TAMBRIDONB 292'6.29 SORAMIN SODIUM 2941.10 TAMBTICILLIN 3902.90 SORFOMBR 2921.45 TAMBTRALINB 2930.90 SORICAINIDB 2933.39 TAMITINOL 293t.90 SORICLONB 2922.19 TAMOXIFBN 2933.90 SORONACRINB 2933.90 TAMPRAMINB 3507.90 Stn'ILAINS ** TAMSOLOSIN 2923.90 SOXAMBTHONIUM 2934.90 TANDAMINB CHLORIDB 2933.59 TANDOSPIRONB 2933.39 SUXBMBRID 2933.59 TANIPLON 2923.90 SOXBTHONIUM CHLORIDB 2932.90 TAPROSTBNB 2933.19 SOXIBOZONB 2933.59 TASULDINB 2933.69 SYMCLOSBNB 2921.19 TAURINB 2922.29 SYMBTINB 2934.90 TAUROLIDINU.. · •. t t t Table. 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their con:esponding HT · tbheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World! Health Organization. Two aste~isks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheadinq INN subheadinq INN
2935.00 TADROMDSTINB 2902.90 TBMAROTBNB 2931.00 TADROSBLCHOLIC ACID 2933.39 TBMATROPIUM MBTILSULFATB 2934.90 TADROSTBINB 2933.90 TBMAZBPAM 2934.90 TADRULTAM 2930.90 TBMBFOS 2933.90 TAZADOLBNB 2933.59 TBMBLASTINB 2933.90 TAZANOLAST ** TBMOCAPRIL 2934.20 TAZASOBRATB 2941.10 TBMOCILLIN 2934.20 TAZBPROFBN 2933.90 TBMODOX 2939.50 TAZIFYLLINB 2933.90 TBMOZOLOMIDB 2934.90 TAZIPRINONB 2932.90 TBMURTIDB 2941.10 TAZOBACTAM i 2932.90 TBNAMFBTAMINB .,, 2934.10 TAZOLOL 3002.90 TBND.AMISTAT \0 2934.10 TBBATIZOLB 2934.90 TBNIDAP 2914 .50 TBBUFBLONB 2934.90 TBNILAPINB 2933.40 TBBUQUINB 2934.90 TBNILOXAZINB * TBBUTATB 2934.90 TBNILSBTAM 3507.90 TBCBLBUKIN 2934.90 TBNIPOSIDB 2844 .40 TBCHNBTIUM (99m Tc) BICISATB * TBNOATB 2844 .40 TBCHNBTIUM (99m Tc) SBSTAMIBI 2934.90 TBNOCYCLIDINB 2844.40 TBCHNBTIUM (99m Tc) SIBOROXIMB 2934.10 TBNONITROZOLB 2844 .40 TBCHNBTIUM (99m Tc) TBBOROXIMB 2934.90 TB NOSAL 2935.00 TBCLOTHIAZIDB 2934.90 TBNOSIPROL 2924.29 TB CLO ZAN 2939.90 TBNOXICAM 2933.90 TBDISAMIL 2934.90 TBNYLIDONB 2933.29 TBFAZOLINB * TBOCLATB 2933.39 TBFBNPBRATB 2939.50 TBOPRANITOL 2933.59 TBFLUDAZINB 2939.50 TBOPROLOL 2903.40 TBFLURANB 2933.39 TBPIRINDOLB 2934.90 TBFLUTIXOL 2933.19 TBPOXALIN 2934.90 TBGAFUR 2914 .19 TBPRBNONB 2941.90 TBICOPLANIN * TBPROSILATB 2934.90 TBLBNZBPINB 2933.79 TBPROTIDB 2934.10 TBLMBSTBINB· 2934.90 TBRAZOSIN 2933.89 TBLUDIPINB 2933.40 TBRBBQUINIL 'lC)'U - ~g TRMAFLOXACIN 2921.49 TBRBINAFINB Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS HTS subheading INN subheading INN
2932.90 TBRBUCRCllIL 2933.90 TBTRAZBPAM 2918.90 TBRBUPIBROL 2933.90 TBTRIDAMINB 2918.29 TBRBUPICIN 2916.39 TBTRIPROFBN 29.09 .49 TBRBOPROL 2932.29 TBTRONASIN 2922.50 TBRBtJTALINB 2914 .69 TBTROQUINONB 2933.59 TBRCIPRAZINB 2933.59 TBTROXOPRIM 2934.90 TBRCONAZOLB 2923.90 TBTRYLAMMONIUM BROMIDB ** TBRDBCAMYCIN 2933.29 TBTRYZOLINB 2933.39 TBRFBNADINB 2932.90 TBXACROMIL 2934.90 TBRFLAVOXATB 2925~19 THALIDOMIDB 2908.10 TBRFLURANOL 2939.10 THBBACON I 2933.90 TBRGURIDB 2934.90 THBNALIDI~ l.tJ I 2934.90 THBNIUM CLOSILATB 0 ** TBRIKALANT 2933.29 TBRIPARATIDB ... 2934.90 THBNYLDIAMINB 2934.90 TBRIZIDONB 2939.50 THBODRBNALINB 2934.90 TBRLIPRBSSIN 2939.50 THBOPHYLLINB BPHBDRINB 2933.29 TBRNIDAZOLB 2931.00 THIACBTARSAMIDB SODIUM - 2924 .49 TBRODILINB 2933.51 THIALBARBITAL 2922.50 TBROFBNAMATB 2934.90 TIAGABINB 2933.59 TBROXALBNB 2916.39 TIBBGLISBNB 2934.90 TBROXIRONB 2930.90 TILUDRONIC ACID 2934.90 TBRTATOLOL 2934.90 TIMIRDINB 2925.19 TBS I CAM ** TINZAPARIN SODIUM 2925.19 TBSIMIDB 2933.90 TIRACIZINB 2932.29 TBSTOLACTONB 2933.59 TIRILAZAD 2937.99 TBSTOSTBRONB * TOFBSILATB 2937.99 TBSTOSTBRONB KETOLAURATB 2922.19 TOLTBRODINB 2933.51 TBTRABARBITAL 2934.90 TOPOTBCAN 2933.90 TBTRABBNAZINB 2937.91 TORIPRISTONB 2922.49 TBTRACAINB 2933.90 TRANDOLAPRILAT 2937.29 TBTRACOSACTIDB 2933.59 TRELNARIZINB 2941.30 TBTRACYCLINB * TRICLOFBNATB 2923.90 TBTRADONIUM BROMIDB 2915.39 TRIFLUTATB 2925.19 TBTRAMBTHRIN 2933.90 TROPISBTRON 2934.90 TBTRAMISOLB 2934.90 TROQQID~0!1B Table 1--Continued Tariff Classifications: Pharmaceuticals having an INN and their corresponding HTS subheadings (One asterisk (*) denotes INN names for radicals and groups proposed by the World Health Organization. Two asterisks (**) indicate that either structural information was not available at time of classification or description is too general to classify.)
HTS subheading INN
• TROXONDATB 2934.90 TULOPAPANT 2933.59 UMBSPIRONB 2934.10 tn"IBAPRIL 2934.90 tn"IBAPRILAT 293.3 .39 VAMICAMIDB 2933.59 VANOXBRINB 2933.90 . VAPRBOTIDB 2933.40 VBRLUKAST 2933.90 VINFOSILTINB 2933.90 VINLBUCINOL 2933.90 VINTOPBROL ....w 2922.50 VOGLIBOSB 2933 .90 VOROZOLB 2934 .90 VOXBRGOLIDB • XINAFOATB 2933.39 ZABICIPRILAT 2933.51 ZALOSPIRONB 2934.90 ZALTOPROFBN 2933.39 ZATBBRADINB 2932.40 ZATOSBTRON 2933.51 ZBNARBSTAT 2931.00 ZBNIPLATIN 2934.90 ZIDOVUDINB 2932.19 ZILASCORB (2H) 2934.90 ZILIWl'ON 2933 .·90 ZILPATBROL 2930.90 ZOPBNOPRILAT 2934.20 ZOPOLRBSTAT
APPENDIX A COPY OF THE LETTER OF REQUEST FROM THE UNITED STATES TRADE REPRESENTATIVE THE UNITED STATES TRADE REPRESENTATIVE r ::- - :- · · · ::- ;"1 Executive Office of the President - ·· ·· ..... ·:-' '.=-~·::' ,·..,-:.--._~".'"-·-Washington. O.C. 20506 • ' I '""" • • ' •• ·- ._,; •• • • ,,_..;
The Honorable Don E. Newquist Chairman U.S. International Trade Commission 500 E Street SW Washington, o.c. 20436 Dear Chairman Newquist: l- An important element in the Uruguay Round market "1ccess ~: negotiations is the u.s. "zero-for-zero" initiatae. ··Th-is initiative provides for reciprocal duty-free treaement .. among major trading partners in several product sector~ 'ni~ . pharmaceuticals sector is one of the most promising in this initiative. To successfully conclude the agreement on pharmaceuticals, however, technical assistance is urgently needed from the Commission and the U.S. Customs Service. The pharmaceuticals agreement contemplates providing duty-free ·treatment for all pharmaceutical products having an International Nonproprietary Name (INN) assigned by the World Health Organization, the salts and esters of those products, and specified intermediate chemicals used principally in the production of pharmaceuticals. currently about 7,ooo pharmaceuticals have an INN. For reasons of international transparency, and to facilitate the implementation and monitoring of the agreement, it is intended that all INN products covered by the agreement will be listed in an annex to the agreement, together with the applicable 6-digi~ subheading of the Harmonized System (HS) in which each of the products is classified. It is in this area that the technical ·eA-pertise of the staffs of the Commission and the Customs service is required. Under authority delegated by the President, pursuant to section 332. (g) of the Tariff Act of 1930, I request that the Commissior. institute an investigation for the purpose of providing my off i=e with a report listing the 6-digit HS subheading for each pharmaceutical:currently having an INN and each intermediate chemical product to be covered by the proposed pharmaceutical agreement. The report should identify each instance where the~e is a known difference in opinion among countries on the correc~ classification of a product. I have already provided a data ~3~e of INN products to your staff.
A-2 - 2 - our negotiating partners in the pharmaceuticals sector are engaged in a similar review, based principally upon work that has been done by the European Community, with a view to achieving the best possible common understanding on the classification of the products included in the agreement. To facilitate our multilateral procedures, and particularly the resolution of any differences among countries on the classification of products, the results of the Commission's wor~ in this investigation should be provided to my office, and also made available to the public, on a flow basis, as separable _segments of the work are completed. It is important for our schedule that the final report be submitted no later than June 1, 1992.
In order to carry'~ut this request, it is understood that the commission staff will have to work closely with the U.S. customs Service. I am therefore requesting the Commissioner of Customs to provide whatever technical assistance the Commission requires to accomplish this task. Your assistance in this work is greatly appreciated.
Carla A. Hills CAH:ebj
~3
APPENDIX B COPY OF THE COMMISSION'S NOTICE OF INSTITUTION OF INVESTIGATION, AS PUBLISHED IN THE FEDERAL REGISTER .Federal Resister:/ Vol. 57, No. -38 I Wednesday, February 28, 1992· / Notices · 6619·
provisions of the Federal Advisory (INN) and certain intermediate oxobutoxy-1 beta Committees Act. chemicals (used primarily in the naphthaleneheptanoic acid. ,...... production of pharmaceuticals) to be ammonium ult &gional Dir«:tor. covered in the proposed "zero-for-zero" 3-(2-Cbloro-4.5-difiuorophenyl)-3- (FR Doc. 92-4339 Filed ~ 8:45 am) initiative on pharmaceuticals currently oxopropionic acid ethyl ester being negotiated in the Uruguay Round ~coma•,... Ethyl-2-oxo+phenylbutanoate market access negotiations. In her 16-alpba-Methyl-l.4-pregnadiene-17- request letter, the USTR asked the alpha. 21-diol-3.20-dione. 21 acetate INTERNATIONAL TRADE Commi11ion to make its work available (&-alpha. 11-beta, 16-alpha. 17-alpha)- COMMISSION both to her office and the public on a 6.9-Dlfluoro-11.17-dihydroxy-16- flow basis. Per the USTR's request. the methyl-3-oxoandrosta-1.4-diene-17 - (Investigation No. 337-TA-335] following intermediate chemicals will be carboxylic acid considered in this investigation: Certain Dynamic Sequential G,.dlent 21-Acetoxy-17-alpha-hydroxy-16-beta De¥lc:el; o.tgnatlon ot Addltlonat 1.1'-{4-Cblorobutylidene)bis(4- methylpregna-1,4-diene.3.20-dione Commisllon lnvestlpttve Attorney fluorobenzene) Pregna-1.4-diene-3.20-dione. 21· m-Chlorobenzyl chloride · ((ethoxycarbonyl)oxy}-17-hydroxy-1& Notice is hereby given that. as of this 4-Cbloro-3-nitrotrifluoromethylbenzene methyl-ll·((methylsulfonyl)oxy)-. (11· date. Linda C. Odom. Esq. and Sarah C. Isophytol alpha-. 16-beta) Middleton. Esq. of the Office of Unfair Sodium 4-Chloro-1-hydroxy-1-butane Pregna-1.4,9-(11)-lriene-3.20-dione.21- Import Investigations are designated as sulphonate ((ethoxycarbonyl)oxy)-17-hydroxy-1&- · the Commission investigative attorneys 2-Bromo-&-methoxynaphthalene methyl-, (16-beta) in the above-cited investigation instead 3-Chloropropyl-2.5-xylyl ether Diethyl ethoxymethylene malonate of Linda C. Odom. Esq. Oxirane{(4-{2· Dihydro phenyl glycine The Secretary is requested to publish methoxyethyl)phenoxy }methyl] this Notice in the Federal Register. Ethyl-2-(2-chloro-4.5-diDuoro-benzoyl)-3- Diisopropoxycyclobexane (2.4-diOuoro phenyl-amino)-2-acrylate Dated: February 19. 1992. 9.t~Ethanoanthracene-9(10H)-acrolein alpha', alpha', alpha'-Trifluoro-2.3- LYuLLniDe. 8-Methoxy-2-naphthalehyde · xylidine DirKIDr, Office of Unfair Import lsobutyl acetophenone 1-Naphthaleneamine.4-(3.4- lnve•tigatiOM. 4-Chloro-1-{4-fluorophenyl)-1-butanone dichlorophenyl)-1.2.3.4-tetrahydro-N (FR Doc. SZ-4388 Filed Z-%5-92: 8:45 am) 5-H-Dibemo-(a;d]-cyclophepten-5-one methyl-hydrochloride, trans-(.+·.) 2-Chloro-1(2.4-dichlorophenyl) ethanone ~com~ N-Benzylmetbylamine 10.11-Dihydro-SH-dibenzo..[a,d]· 1-Deoxy-1-(octylamino)-D-glucitol cyclobepten-5-one [lnvHtlptlon No. 332-322) . 2(S.3RH + )+Dimethylamino-3-methyl- Pregna-1,4-diene-3.2(kiione.11.17.Zl· 1.2-diphenyl-2-butanol . trihydroxy-16-methyl-. (11. alpha.. 2·(3.4-Dimethoxyphenly)ethylamine Certmn Phannaceutlcals and . 18.beta) Intermediate Chemlc:als: ldentfflcatlon 2-Amino-2' -chloro-5-nitrobenzophenone 9-beta.11-beta·Epoxy 17-alpha. 21· of AppUc8ble &-Digit HS SUbttndlnga dihydroxy-16-beta-methylpregna-1.4- (S.S)·H·(l-Carboethoxy-3-phenyl- tor Prod&lcta CoV81'9d by the Propo8ed diene-3.»dione (9,11-epoxide) propyl)alanine Uruguay Round Ptlarmeceutlc:a 21-Acetoxy-17-alpha-hydroxy-1&-beta 4-Amino butric acid Agreement methylpregna-l,4,9-triene-3.20-dione Benzenacetic acid. alpha-methyl-4-(2· methylpropyl)-(S)-. compound with I. AGENCY: United States International 0-(-)-3-Acetylthio-2-methyl propanoic Trade Commission. . acid · · lysine (1:1) Sodium D(-)-alpha-[(3-methoxy-1- ACTIOIC Institution of investigation. Methyl-{RH -)-3-hydroxybutyrate Isobutyl-3.4-epoxybutanoa te methyl-3-oxo-1-propenyl)-amino I· DncnvE DATE February 14. 1992. alpba-(2-Bromoethyl)-alpha- phenyl acetate FOii FUll'TMell INl'OllMATION CONTACT: phenylbenzeneacetic acid Pota11ium D(-)-alpha-((methoxy-1· General inquiries regarding the 2-Chloro-4~uorobenzoic acid methyl-3-oxo-1-propenyl)-amino]· investigation may be directed to Ma. ((2-Methyl 1·) 1-oxyl propoxy) phenyl acetate Elizabeth R. Nesbitt (202) 205-3355, (propoxyH4-phenylbutyl 1) trans+Cyclohexyl-L-proline Energy and Chemicals Division. Office phoaphinyl] cinchonidine salt hydrochloride of Industries, U.S. International Trade ((2-Methyl-1)-1-oxyl propoxy) (propoxy)- 2-Butenoic acid.3-amino-.methyl ester Commission. Washington. DC 20438. For (4-phenylbutyl 1)-phosphinyll acetate Pota11ium 0(-)-alpha ((3-methoxy·l· information on legal aspects of the Mono-4-nitrobenzyl malonate methyl-3-oxo-l-propenyl)-amino J+ investigation contact Mr. William magnesium salt dihydrate hydroxy phenyl acetate Gearhart of the Commi11ion'a Office of Monophenyl phenyl malonate Sodium 0(-)-alpha-((3-methoxy-1- the General Counsel (202) 205-3091. D(·)alpha-Formyloxy-alpha methyl-3-oxo-1-propenyl)-amino)+ SUMlllAllY: Following receipt on January phenylacetyl chloride hydroxphenyl acetate %7, 1992. of a request from the United Calcium lactate gluconate 0(-)-4-Hydroxyphenyl glycine States Trade Representative (USTRJ. the 8(S)-(2.2·dimethyl-1-oxobutoxy )· N-Benzyl-N-tert-butyl-2-hydroxy-2-(3' - Commission instituted investigation No. 1.2.6.7.8.8-alpha(R). he'tahydro- hydroxymethyl-4' • 332-322 under section 332(g) of the Tariff beta(RJ, delta (R)-dihydroxy-:?(S), hydroxyphenyl)eth)·lamine Act of 1930 (19 U.S.C. 1332(8)) for the 6(R)-dimethyl-1(S)· Benzene-ethanamine-3.4-dimethoxy purpose of providing a report listing the naphthaleneheptanoic acid. bctamethyl &-digit Harmonized System (HS) ammonium salt 4-Hydroxy-alpha-1-({6-(4- subheading for each pharmaceutical 1.2.6.7.8.8-alpha-Hexahydro beta. &eta, phenlybuyoxy )hexyl}-amino }methyl 1- product currently having an delta. beta-dihydroxy·2 beta. 6 alpha· 1.3-benzenedimethanol International Non-proprietary Name dimethyl-a alpha-(2 beta-methyl-1- D(-)-alpha-Phenylglycine
B-2 Federal Register I Vol. 57. No. 38 I Wednesday. February 26, 1992 I Notices
4-Amino-5-chlorn-2-methoxybenzoic alpha-(2.4-Dichlorophenyl)·lH- 7-Chloroquinaldine acid imidazole-1-ethanol l·Amin0-4-methylpiperazine 2-(N-Benzyl-N-tert-butylamino}-4· - Calcium-bromide lactobiomate 1-Cyclopropyl-6.7-difluoro-1.4 dihydro-4 hydroxy-3' - Calcium lactobionate dihydrate oxo-3-quinoline carboxylic acid hydroxymethylacetophenone Lactobionic acid 1-Ethyl-6.&-Difiuoro-1.4-dihydro-7-(3- hydrochloride N-(Dihydro-3.3-diphenyl-2(3H)- methyl-1-piperazinyl )-4-oxoquinoline- l:!S.3R)-( + )·2-(15)-Hydroxyeth)•l-3- furanylidene)-N 3-carboxylic acid amino-1.5-pentane-dioic acid-5 methyl me:hylmethanaminum bromide 2.4-0idydroxy-6.7-dlmethoxy ester Anthra(1,9-cdl pyrazol-6(2H)-one.7.10- quinazoline 2-(Aminooxy)-2-methylpropanoic acid. dihyd:-oxy-2 (2-((Z.. monohydrochloride 1-(Z-Furoyl)piperazine hydroxyethyl )amino )ethyl)-5-[(2- N-(Z-Tetrahydrofuroyl)-piperazine N-(2-Hydroxyethyl)actamide methylamino )ethyl)aminoj 3-(2-Chloroeth}·l)-2-methyl-4H-pyrido 2.2-Dlmethylcyclopropylcarboxamide 1.2-Diphenyl-4-(2.phenyltbioethyl)-3.S 5-(N.N-Dibenzylglycyl)aalicylamide pyrazolidinedione (1.2-a )pyrimidine-4·one · 3-I (Dimethylamino )methyl )-1.z.3.9- 2-Propyl-4(5)-carbomethoxy-5(4} 1 ·(Diphenylmethyl)piperazine tetrahydro-9-methyl-4H-carbazol+ . pentafluoroethyl imidazole 1-(alpha.alpha-bis( 4- one 1-( 3-Chloropropyl)-2.6- fluorophenyl)methyl)piperazine 1.2.3.9-Tetrahydro-9-methyl-3-((2-methyl- dimethylpiperidine hydrochloride 1.3-Dimethyl-4-amino-5- 1H-irnidazol-1-yl) metbylj-4H 2-Methyl-4(or 5)-nitro-imidazole fonnylaminouracil carbazolone 4-Methylimidazole 4-(4-(1-Methylethyi}-1- Methyl 3-chloro+acetamido-6- 2-Chloronicotinic acid • piperazinyl)phenol methyoxy-benzoate 2.~Dichloro-5-fluoronicotinic acid 5.6-Dimethoxy+pyrimidinamine N-(Benzyl oxycarbonyl)-DL-valine 3.5-Dimcthyl-2-hydroxymethyl+ 1-Acetyl+(4-hydroxypbenyl) pipera:r:ine 1.2.3.9-Tetrahydro-9-methyl-IH methoxyp}Tidine 1-(2.6-DichlorophenylJ-2-indolinone carbazol-t-one N-Acetylsulfanilyl lH-Imidazole+carboxaldehyde, 2- 3.3-Diethyl-5-(hydroxymentylJ-2.4- chloride butyle-5-chloro-( +I - )-cis-4-Amino-5- (1H.3H)-pyridinedione 2-f 4-{2-Hydroxy-3-isopropyl 1 'R,35.4R )-4-Acetoxy-3-(1 '-tert-butyl aminopropoxy)phenyl} acetemide chloro-N-(1~(3-{4-fluoro 2-Methyl-N-{3- phenoxy)propylj-3-methoxy+ dimethyl-silyloxy J ethyl) azetidine-2- ( trifluoromethyl}phenyl)propanamide piperidinyl J-2-methoxybenzamide one Formylisopropylamide · methanol (1:1) . 3-0xy-4-aza-5-alpha androstene-17-beta Ethyl 4-((Z..amino+ carboxylic acid 2.~Piperidinedione 4-(4-chlorophenylJ Ethyl ethoxymethylene cyanoacetate chlorophenyl)amino)-1· S-Ethenyl-2-pyrrolidone-3-carboxamide (1 )-N-{a!pha-Cyano+bydroxy-3- piperidinecarboxylate 3-0xy-4-aza-androst-5-ene-17-beta methoxy-alpha methylphenethyl) N-( 4-(Methoxymethyi}-4-piperidinyl)-N carboxylic acid acetamide _ phenyl-propanamide Methyl-3-oxo-4-aza-5-alpha-andros t-1- alpha-Iaopropyl-3,4,5-trimethoxybemyl mono hydrochloride ene-17-beta-carboxylate cyanide (4-Fluorophenyl)(4-pipericlinyl) 8-Methoxypaoralen 2·(3-Phenoxyphenyl)propiononitrile methanone 4-methylbenzeneaulfonate (1S)-Z..Methyl-Z.5-diazabicyclo[ll1i 1-( 4-Fluorophenyl)-4-oxocyclohexane (1:1) heptane dihydrobromide carbonitrile ( - )-trans-3-Methyl+phenyl-4- lH-Imidazole-5-methanol 2-butyl+ Alpha-Iaopropyl-3,4-dimethoxy piperidine-carboxylic acid chloro-1-{(Z' -lH-tetrazol-5-yl) (1.t'• benzylcyanide hydrobromide biphenyl) -4-yl)methyl) N-para-Chlorobenzoyl-N-para- Ethyl 4-oxo-1-piperidinecarboxylate monopotassium salt methoxyphenylhydrazine alpha-Phenyl-2-piperidine acetic add lH-Imidazole-5-methanol. 2-butyl-4- Dimethyl N-cyanodithioiminocarbonate 3-Ethyl-~methy1+(2-c:hloropbenyl)-t.4- chloro-1-{(2' -(lH-tetrazol-5-yl) (1.1 "- 2-Naphthylchlorothioformate dihydro-2·(z..(1.3-dihydro-1.3-dioxo- biphenyl)-4-yl)methyl)-.potaaaium salt cis-5-Fluoro-2-methyl-1-(para- 2H-isoindol-2-yl) ethoxy (methyl~ lH-lmidazole-S-methanoL 2-butyl-4- methyl-3.5-pyridine dicarboxylate methylthiobenzylidene)-indo-3-acetic chloro-1-((2' -1H-tetrazol-5yl)-1, acid ci&-1·(3-{4-Fluorophenoxy) (t.1 '-bipbenyl-4-yl)methyl)-. N.N-Dimethylaminothioacetamide propyl]-3-methoxy+piperidinamine hydrochloride N-Phenyl-N-(4-pipericilnyl)propana.mide monohydrochloride salt N-Methyl-1-(methylthio)-Z.. Quinuclidine lH-Tetrazole. 5-(4' -methyl(l.1'- nitroetheaamine Chloro-7~thyl-1-Ruoro-4k>xo-4-dihydro- bi phenyl}-Z..yl}-1-triphenylmethyl 4-Amino-N 1,4-quinoline-3-carboxylic acid (1.1 •-Biphenyl:j-2-carbonitrile. 4' -methyl methylbemenemethanesulphonamide 3-lsoquinolinecarboxylic acid S.1.z.3.4- tH-lmidazole-5-methanol. 2-butyl-4- hydrochloride · tetrahydro, benzyl ester. para· chloro-1-((2' -(lH-tetrazol- 5-yi)-1, 1'· N-(2-Mercaptoethyl)-propanamide toluenesulfonic acid aalt biphen)i}-4-yl)methyl)-, sodium salt Tertiarybutyl (triphenyl 2-Quinolinemethanamine,1,2.3,4- Trifluoroacetyl-L-lysine-L-proline tosyl phosphoranylidine) acetate tetrahy~methyl salt N-( 2-((5-0imethylamino)methyl)Z.. N-{1-methylethyl}-7-nitro 2-Mercapto-5-methoxy benzimidazole furanylmethyl)thio)-ethyl)-N-methyl-2- monomethanesulfonate Terfenadone nitro-1.1-ethenediame 6,7-Difluoro-1(2.4-dilluoropbenyl)-1.4- 1-Carboethoxymethylpyrrolidin-2-one 5[(2-~oethyl)thio)methyl-N.N dihydro-4-o~3-quinolone carboxlic 2.H-lndol-2-one, 1.3-dihydro-1-phenyl-3.3- dimethyl-2-furan methanamjde acid bis diamine 7-Chloro-8-fiuoro-1-(4-Duorophenyl)-1.4- (4-pyridinylmethyl) DL-Dihydro-3-bydroxy-4.4-d.imethly- dihydro-4-oxo-3-quinoline Galboxylic 5-Mercapto-1-methyl-1.2.3.4-tetrazole 2(3H)-furanone acid lminostilbeu D-{-)-Dihydro-3-hydroxy-4.4-dimeth)·l- Ethyl-ethyl-e.:7.B-triDu.oro-4-dihydro+ Pyrazine carboxylic acid. 3-amino-s.& 2(3H)-furanone oxo-3-quinoline carboxylate dichloro. methyl eate:
B-3 Federal Realster I Vol. 57, No. 38 I Wednesday, February 28, 1992 I Notices 6621
25-1-(3-Acetylthio-2-methyl-1- · 2',4'-DiOuoro-2-(lH-1.2.4-triazol-1-ylJ (7RJ-7-Amino-3-{(5-methyl-1.3.4- oxopropylJ-L-proline acetophenone hydrochloride thiadiazole-2-ylJ-thio)methyl}-3- Tetrazole-1-acetic acid 4-(4-Bromophenyl }-4-pleridinol cephem-4-carboxylic acid L-alanyl-L-proline 2-{Fonnylamino)-alpha-oxo+thiazole 7-Amino-3-((1-methyl-tetrazole-S-yl) Trifiuoroacetyl-L-lysine-L-proline acetic acid thiomethyl)-cephaloaporanic acid Iminodibenzyl Ethyl-2-(2-aminothiazole-4-yl)-2- 3-(2.6-Dicblorophenyl)·S 8-ChlonHJ-(2-0uorophenyl}-1-methyl-4H- hydroxyiminoacetate methylisoxazole-4-carboxylic acid imidazo (t.5-aj (1-4) benzodiazephine- 2-(Fonnylamino)-thiazolyl-4-glyoxylic chloride 3-carboxylic acid acid ethyl ester Stavudine 04T 7-Chloronaphthyridine ethyl ester Amino-2-pbenothiazine (3aS.6aR)-1.3-Dibenzyltetrahydro-4H 4-(MethoxymethylJ-N-phenyl-1- Chloro-2-phenothiazine furo (3,4-d) imidazole-2.4 (lH)-dion (phenylmethylJ-4-piperidinamine Acetyl-2-phenothiazine 3-(2-Chloro-8-fluorophenyl)-S Tetrazole-1-acetic acid 2-{3,4-Dihydropxyphenyl-tetrahydro-1.4- methylisoxazole-4-carboxylic acid L-alanyl-L-proline oxazine chloride Trifiuoroacetyl-L-lysine-L-proline ZH-1.2-Benzothiazine-3-carboxylic 2·Thiophene acetyl chloride lminodibenzyl acid.4-hydroxy-2-methyl-ethyl (+ }-8-Amino-penicillanic acid 8-ChlonHJ-( 2-fiuoropbenyl}-1-methyl-4H ester.1.1-dioxide 7-Amino cephalosporanic acid imidazo (1,S-a) (1-4) benzodiazephine- 7-Amino-3-methroxymethyl 1·Ethyl-t.4-dihydro-4-oxo-(1.3) dioxolo 3-carboxylic acid cephalosporanic acid (4,5-g) cinnoline-3-carbonitrile 7-Chloronaphthyridine ethyl ester lmperatorin 4-(Methoxymethyl}-N-phenyl 7-Amino-desacetoxycephalosporanic cis-2-(2.4-0ichlorophenyl)·2·(1H-1.2.4- (phenylmethyl)-4-piperidinamine acid triazol-1-ylmethyl)·1.3-dioxolane-4- 2.4-Dihydro-4-{ 4-(4-(4-hydroxyphenyl}-1- 2-(2-Formamidothiazol-4-yl)-2- methanol piperazinyl}-2-(1-methylprophyl J-3H- methoximido acetic acid cis-2-(2,4-Dichlorophenyl)-2·(1H 1.2.4-triazol-3-one 4-Thia-1-azabicyclo (3.2.0) heptane-2- imidazol-1·ylmethyl)-1.3·dioxolane-4· 1-((4-Fluropheny)methyl)-N-(4- carboxylic acid 3.3-dimethyl-7-oxo methanol methanesulfonate piperidinyl)-lH-benzimidazol-2-amine iodomethyl ester, 4.4-dioxide, (25-cis) monohydrochloride 1.3-0ihydro-1-(4-piperidinyl)-2H- Piperazine.1-((2.3-dihydro-t.4- 2-Chloro-9-l 3-dimethylamine)-propyl )· ' benzimidazol-2-one benzodioxin-2-yl)-carbonyl J 9H-thioxanthen-9-ol (Z)-3-(2-(4[(2.4-DiOuorophenylJ monohydrochloride 2-(2.4-0ichlorophenyl)-2-(lH-imidazol- (hydroxyimino}-methyl)-1-piperidinyj (6R.7R}-7-({R)-2· 1,3-dioxolane- ethylj-8.7.8.9-tetrahydro-2-methyl-4H Aminophenylacetamido)-3-methyl-8- 4-methanol pyrido (1.2-a) pyrimldin-4-one oxa-S-thia-1-azabicyclo (4.2.0) oct-2· 3-Thiophene malonic acid 3-(2-Chloroethyl)-8,7,8,9-tetrahydro-2- ene-2-carboxylic acid disolvate (1-beta )-8- methyl-4H-pyrido(l.2-a) pyrimindin-4- 2-Acetylbenzo-(beta)-thiophene (Pbenoxyacetyl)amino )penicillanic one monohydrochloride (6R.7R)-7-Amino-3-chloro-8-oxa-4-thia·l acid. (4-nitrophenyl) methyl ester. 1- 1.3-0ihydro-1-(1.2.3.6-tetrahydro-4- azabicyclo (4.2.0) oct-2-ene-2- oxide pyridinyl)-ZH-benzimidazol-2-one carboxylic acid, (4-nitrophenyl) 3·Phenyl-S-methylisoxazole-4-carboxylic 3-Aminopyrrolidine dihydrochloride methyl ester acid chloride 3-(2-ChloroethylJZ.4-(lH. 3H)· 3-Methylene-7-(2-phenoxyacetamido) 3·(2-Aminoethyl)-N-methyl-lH·indole-5- · quinazolinedione cepham-4-carboxylic acid, para-nitro methanesulphonamide ·· N-(N-( (S )-1-Carboxy-3-phenyl-propyl] benzyl ester. 1-oxide 5-Chloro-2.4-disulfamoylaniline 2-Chlorodibenz-(beta,f)-(1,4)-oxazepin- N' -trifluoracetyl)-1-lysil)-L-proline N-(2-(4-Aminosulfonyl)phenyl)ethyl-5· ethyl ester 11-(10-H)-one {R)-3-(2-Deoxy-beta-D chloro-2-methoxybenzamide S-Chloro-1.3-dihydro-1-(4-piperidinyl)· 4-Hydrazine-N-methylbenzene 2H-benzimidazol-2-one erythropentofuransoyl )· methanesulphonamide hydrocbl~ride 2.3-0ihydro-1-methoxy carbonyl-lH 3,4,7,8-tetrahydroimidazo-(4.5) (1.3) pyrrolizine-7-carboxylic acid diazepin-8-ol 5.6-Dihydro-4-oxo-thieno-(2.3-beta) thiopyran-2-sulfonamide t-1 (4-Fluorophenyl)metbyl}-tH 7-0(-)-Mandelamidocephalosporanic benzimidazol-2-amine acid 5,6-0ihydro-4-oxo-4.H· thieno-(2.3· 2.S-Oihydro-S-thioxo-IH-tetrazole-1- betha )thiopyran-2-sulfonamide-7.7- Ethyl 4-(5-chloro-2.3-dihydro-2-oxo-lH methanesulphonic acid. disodium salt benzimidazol-1-yl)-1· dioxide S-Methyl-t.3.4-thiadiazole-2-thiol delta-9.11-Anhydro-16-alpha piperidinecarboxyla te 4-Chlorobenzensulphonylurea, PCBS 4-(4-Chloropheny}-4-piperidinol methyl prednisolone acetate urea Provitamins and vitamins, natural or N-Methyl-2-pyrroleactic acid 3-(2-Chlorophenyl)-S-methylisoxazole-4- reproduced by synthesis (including methyl ester carboxylic acid chloride Ethyl 4-{[1·(4-fluorophenylmethyl)-lH 2', 3'-Dideoxyinosine natural concentrates). derivatives benzimidazol-2-yl) amino}-1- cis-2-(2.4-Dichlorophenyl)-2·(1H-.2.4- thereof used primarily as vitamins. piperidinecarboxylate triazol-1-ylmethyl)·l,3-dioxolane-4- and intermixtures of the foregoing. 1.3-Dihydro-1-(1-methylethenyl)-2H methanol methanesulfonte (ester) whether or not in any solvent benzimidazol-2-one monohydrochloride Hormones. natural or reproduced by 4-Animo-2-chloro-8,7-dimeoxy (6R. 7RJ-3-Acetoxymethyl-7-({RJ-:?· synthesis; derivatives thereof. used quinazoline formyloxy-2-phenylacetamido J-8-oxo primarily as hormones: other steroids :-(2+Din uorophenyl)-1.3-bis-(lH-1.2. i S-thia· l·azabicyclo(4.2.0) oct-2-ene-2· used primarily as hormones triazol-1-y l-2-propanol carboxylic acid (and its sales and Casanthranol 1-Ethyl-1.4-dihydro-5H-tetrazol-5-one esters) Senna extract
B-4 Federal Register / Vol. 57, No. 38 I Wednesda~. Februar"J 26. 1992 I Notices
Acetyldigoxine the above-mentioned dates from the (lnveatigatlona N09. 731-TA-542~4 Ser.naglycosides . omce of the Secretary either in person (Preliminary) I \'egetable alkaloids. natural or· or via a fax reouest to that Office. reproduced by synthesis. and their Copies of these reporta will also be Potassium Hydroa.lde from Canada. Italy, and the UnJted Kingdom . salts. ethers. esters. and other provided to the Pharmaceutical derivatives Manufacturers Association. the Determinations ::-Deox)"-~~~ntose Synthetic Organic Chemical On the basis of the record 1 develope 0-Ribose Manufacturers Association. and the .Z.3.4.6-tetra-O-acetyl-8-0-glucopyranosyl Chemical Manufacturers Asaociation. in the subject investigations. the carbamimidothioate Interested parties are requested to Commission determines.• pursuant to monohydrobromide submit written statements to the . section ;"J:lfa) or t.~e Tariff Act or 1930 .'\:11i!:iiotics (excluding Commission regarding any (19 U.S.C. 16731Jf a)), that there is no dihydrostreptomycinJ . discrepancies between their current rea$n!l11blP. indication that an industry i~ Mucopeptide N-acetylmuran:;·lhydlase classifications for the che:nicals under the liniied States is materialiy injured o hydrochloride consideration and :he classifications threatened with material injury. er that the establishment l'f an indu11t.;· in the C.rtochrome C presented by the Com.mission. On!y United States is materially retarded. by 4-(6-Fluoro-2-methylinden-3-ylmethyl) submissions regarding product reason of im-port9 from Canada. lt11ly. phenyl methyl sulphide in the form of classif!cations will be considered in the a solution in toluene and the United Kingdom or potas!linm Commission's report. Proof of s;ich hydro~ide. provided for in subheading ~-(:?-Aminoethylthiomethyl)-1.3-thiazol- classification confucts are requested 2·}'lmethyl dimethylamine. in the form :?ciS.20.00 of the Har.nonized Tariff either in the form of official n.lings Schedule of thP. United States. that are of a solution in toluene provided by the U.S. Customs Sel'\;ce Crude bile acids alleged to be sold in the United States at (Customs) or in the form of copies Intermediate products of the antibiotics oi less than fair "·a foe (LTFV). prior communicationa with Customs on manufacturing process. obtained from Back~round the fermentation of Streptomyces this iasue. The Commission "·ill work tenebrarius. whether or not dried. for with Customs personnel to resolve any On January z. 1992. a petition was use in the manufacture of human classification conflicts. No confider.tial filed with the Commission and the medicaments of No. 3C04(a) information is requested. No requests to Dep1artment of Commerce by Linchem. Potassium cla\-ulanate/sucrose (1:1) modifv the list of products under Inc.• Ashtabi.;la. OH. alleging that an Potassium clS\"Ulanate/silicon dioxide consideration will be con!!idered by the industry in the United States is (1:1) Commission. materially injured or threatened with Potassium clavulanate/microcryst<1lline To be given consideration. comments material injury by reason of LTFV cellulose (1:1) on the first report must be recei1•ed by import11 of potassium hydroxide from Canada. Italy. and the United Kingdom. Cholic acid and 3-alpha.1.2-alpha close of business (5:15 pm) on March '1.7, Accordingly. effecti\•e January 2. 1992. dihydroxy-5-beta-cholan-24-oic acid 1992. The deadline for the receipt of the Commission instituted antidumping (deoxycholic acid). crude comments on the second interim report Polymerisation products of acrylic acid investigations Nos. 731-TA-542-544 will be close of business May 8. 1992. {Preliminary). with small quantities of a Although confid!Dtial information is not polyunsaturated monomer for use in Notice of the institution of the required. information which a submitter Commission's investigations and of a the manufacture of medicaments of desires the Commisllion to treat as heading no. 3003 or 3004 pul.ilic conference to be held in confidential must be aubmitted on connection therewith was given by The CommiHion was also asked to separate sheets of paper. each marked posting copies of the notice in the Office identify each instance where there is a "Confidential Busine11 lnformation" at of the Secretary. U.S. International known difference in opinion among the top. All aubmissiona requesting Trade Commission. Washington. DC. countries on the claasification of a confidential treatment must conform and by publishing the notice in the producL USTR has requested the with the requirements of I 201.8 of the Federal Register of January 9. 1!192 (57 Commissioner of Customs to provide Commiuioo's Rules of Practice and FR 924). The conference was held in Commission staff with any necessary Procedure (19 CFR 201.8). All written Washington. DC. on January 23.1992. technical assistance. The USTR submissions, except for confidential and all persons who requested the requested that the Commission submit business information. will be avaibable opportunity were permitted to appear in its report no later than June l, 1992. for inspection by interested persons. All person or by counsel. submiasions should be addressed to the The Commission transmitted its WRITTEN SUBMISSIONS: In response to determinations in these investigations tu the USTR"s request that the Commission Secretary at the Commission's office in Washington. D.c.· the Secretary of Commerce on February make its work available to the public on 18. 1992. The views of the Commission Hearing impaired persons are advised a flow basis. the Commiasion plans to are contained in usrrc Publication 2482 r:talr.e available two interim reports on that information on tha matter can be (February 1992), entitled "Potassiwn March 13. 1992. and April 24. 1992. Each obtained by contacting the Hydroxide from Canada. Italy. and the interim report will contain a listing of Commission'• TDD terminal on (202) United Kingdom: Determinations of the. the clasaificationa completed by that ~1810. Commission in Investigations Nos. 73- phaee of the investigation. Anyone Issued: February 19. 1992. TA-5-12-544 (Preliminary) Under the wishing to be put on a distribution list to Tariff Act of 1930. Together With the be co:npiled ahould write or fax ((202) By order of the Cozn.aU11ion. :OS-2186) the Office of the Secretary aa · Kemieth L Maaoa. Secretary. ' Tlw nmnl ia defmed la -. JS11.ztl'l ol lhe soon as poaaible and provide a mailing Commi1sion'1 Ruin of Practice and Procedure I tll address. Interested parties may a:,o !FR Doc. 92-t39t Filed 2-2S-9:?: 8:45 eml CFR zo:" .%1flJ. ob,ain copies of the reports on or after lllL&JllQ COOi ~ • Cuaunwioner Wal90ll not particiD8t"'-"
B-5